Arthropathies in other diseases classified elsewhere

M13_ARTHINOTH

arthritis: An inflammatory process affecting a joint. Causes include infection, autoimmune processes, degenerative processes, and trauma. Signs and symptoms may include swelling around the affected joint and pain.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M14* Cause of death: ICD-10 — M14* 2 out of 7 registries used, show all original rules.	1376
4. Check minimum number of events None	1376
5. Include endpoints None	1376
6. Filter based on genotype QC (FinnGen only)	1376

Control definitions (FinnGen only)

Control exclude: M13_ARTHROPATHIES

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	M13_ARTHINOTH
CONTROL_EXCLUDE	M13_ARTHROPATHIES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M14
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M14
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Arthropathies in other diseases classified elsewhere based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Charcot foot

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	7953	4329	3586
Only index persons	7376	4059	3317
Unadjusted period prevalence (%)
Whole population	0.11	0.12	0.10
Only index persons	0.14	0.15	0.13
Median age at first event (years)
Whole population	57.35	57.57	57.00
Only index persons	56.79	56.82	56.76

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1376	741	635
Unadjusted period prevalence (%)	0.27	0.25	0.28
Median age at first event (years)	55.17	52.75	57.99

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1255: Matched controls
12548

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

+∞

316.4

290

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

33.7

299.0

399

171

M14.6*A52.1

ICD-10 Finland

Charcot's or tabetic arthropathy

+∞

291.3

268

M14.5*E03.9

ICD-10 Finland

Arthropathy in hypothyroidism (E00-E03+)

3037.6

276.4

257

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

15.9

268.3

476

464

M14.6*E10.6

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic neuropathic

+∞

264.1

244

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

43.3

263.5

329

102

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

38.6

251.1

322

111

A10AE04

ATC

insulin glargine; parenteral

13.0

250.3

493

594

103

Kela drug reimbursment

Diabetes, insulin-treated

8.3

249.8

768

2011

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

15.1

240.8

434

425

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

20.8

216.8

336

217

215

Kela drug reimbursment

Diabetes, non-insulin-treated

7.2

212.4

690

1822

M14.6

ICD-10 Finland

Neuropathic arthropathy

+∞

210.5

196

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

22.9

208.3

311

178

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

18.5

198.9

321

228

A10AA02

ATC

19.6

184.4

290

189

A10AE05

ATC

insulin detemir; parenteral

14.9

182.9

324

286

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

19.6

181.8

286

186

A10AA01

ATC

23.8

174.0

255

133

T89

ICPC

Diabetes insulin dependent

17.1

167.3

277

204

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

23.3

166.8

246

130

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

18.7

162.3

259

172

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

98.9

156.8

171

C03CA01

ATC

furosemide; systemic

5.7

155.9

585

1675

J01FF01

ATC

clindamycin; systemic

5.5

154.2

606

1825

H3603, E103

ICD-10 Finland

50.5

150.7

182

A46

ICD-10 Finland

Erysipelas

7.3

147.9

410

784

NHQ40

NOMESCO Finland

Amputation of toe

48.3

143.6

175

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

36.2

139.6

181

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

32.0

137.6

184

S97

ICPC

Chronic ulcer skin

13.5

133.0

243

219

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.4

132.2

759

3223

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

27.7

130.1

181

SPAT1262

SPAT

Handing over of treatment supplies

5.3

127.8

476

1287

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

28.3

124.5

172

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

74.8

123.7

140

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

4.8

120.1

517

1612

SPAT1148

SPAT

Treatment of chronic ulcer or burn

6.3

117.0

355

737

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

65.6

116.9

135

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

24.1

116.0

168

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

56.6

111.6

132

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

11.7

111.1

217

221

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

17.5

110.5

179

118

XCK10

NOMESCO Finland

Photography of fundus of eye

6.5

109.5

321

631

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

18.7

107.8

170

104

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

7.7

105.8

267

423

M14.8*D86.8

ICD-10 Finland

Arthropathy in sarcoidosis

+∞

105.7

100

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

47.4

104.8

128

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

24.5

103.0

148

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

57.5

101.8

120

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

70.1

100.6

115

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

9.5

100.5

220

275

L17

ICPC

Foot/toe symptom/complaint

4.4

99.4

448

1408

H04AA01

ATC

glucagon; nasal, parenteral

16.7

99.1

163

111

CKC12

NOMESCO Finland

Photocoagulation of retina

10.4

96.8

200

224

J01MA12

ATC

levofloxacin; systemic

4.6

96.0

406

1192

N02AX02

ATC

tramadol; systemic, rectal

3.6

95.7

639

2805

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

41.3

95.6

120

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

28.0

94.9

131

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

5.7

94.5

308

679

H03AA01

ATC

levothyroxine sodium; systemic

4.1

94.0

472

1623

T90

ICPC

Diabetes non-insulin dependent

4.0

91.6

471

1648

M13.9

ICD-10 Finland

Arthritis, unspecified

22.4

91.5

135

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

10.3

90.4

187

209

WX320

NOMESCO Finland

Spinalanesthesy

4.7

90.3

359

981

M17.1

ICD-10 Finland

Other primary gonarthrosis

11.3

89.8

177

180

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

6.3

89.7

262

501

H43.1

ICD-10 Finland

Vitreous haemorrhage

15.5

88.6

150

109

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

47.2

88.4

108

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

8.5

86.5

202

278

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

57.6

85.8

101

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

41.6

85.4

107

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

18.9

85.1

133

M25.5

ICD-10 Finland

Pain in joint

4.4

84.2

360

1048

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

11.7

82.7

159

153

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

33.0

82.6

109

NH3CG

NOMESCO Finland

Extensive MRI of foot

182.1

82.2

A10AE06

ATC

insulin degludec; parenteral

12.3

81.0

152

139

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.4

80.8

522

2152

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.6

80.7

484

1883

H3603, E113

ICD-10 Finland

29.7

80.4

109

N03AX16

ATC

pregabalin; oral

4.0

80.3

391

1277

M148, L529

ICD-10 Finland

+∞

80.0

M86.6

ICD-10 Finland

Other chronic osteomyelitis

216.1

79.2

I10

ICD-10 Finland

Essential (primary) hypertension

3.1

78.7

842

4936

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

146.0

77.9

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

30.5

77.3

104

J01DB01

ATC

cefalexin; oral

4.2

77.0

1107

8032

CKC15

NOMESCO Finland

Panretinal photocoagulation

29.9

75.4

102

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

12.3

75.2

141

128

A10BA02

ATC

metformin; oral

3.3

74.6

504

2116

205

Kela drug reimbursment

Chronic hypertension

3.4

73.9

477

1934

H3601, E103

ICD-10 Finland

26.6

73.8

103

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

24.3

73.2

105

M79.6

ICD-10 Finland

Pain in limb

3.2

73.1

510

2184

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

749.8

72.9

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

24.0

72.3

104

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

22.2

71.8

106

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

4.7

71.6

276

712

A11CC03

ATC

alfacalcidol; systemic

17.8

71.6

114

M19.0

ICD-10 Finland

Primary arthrosis of other joints

18.9

71.3

111

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

56.1

71.1

H3600, E103

ICD-10 Finland

20.9

70.5

106

H3601, E113

ICD-10 Finland

18.7

70.4

110

E10

ICD-10 Finland

Type 1 diabetes mellitus

14.0

69.3

122

TK800

NOMESCO Finland

Hemodialysis

17.9

69.2

110

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

34.5

69.1

B01AB05

ATC

enoxaparin; parenteral

3.3

68.6

441

1763

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

3.3

68.4

453

1848

CKC10

NOMESCO Finland

Local photocoagulation of retina

16.3

68.0

112

TPH04

NOMESCO Finland

Cathetrisation of vein

3.6

67.9

380

1364

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.2

67.5

297

866

ZXD05

NOMESCO Finland

Urgent procedure

3.0

67.5

528

2417

Z49.1

ICD-10 Finland

Extracorporeal dialysis

29.3

66.3

H36.00

ICD-10 Finland

Diabetic background retinopathy

19.9

66.1

101

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

11.0

66.0

130

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

38.5

65.3

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

14.9

65.1

111

NH3BG

NOMESCO Finland

MRI of foot

105.8

64.5

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

5.7

64.4

200

402

V03AE01

ATC

polystyrene sulfonate; oral

32.5

64.3

L84

ICD-10 Finland

Corns and callosities

11.8

64.3

122

113

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

22.5

64.1

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

53.8

63.9

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

4.1

63.3

282

827

S18

ICPC

Laceration/cut

2.8

63.2

585

2949

TNX34

NOMESCO Finland

Major custom molded cast, unspecified region

19.9

62.9

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

19.9

62.9

M04AA01

ATC

allopurinol; systemic

5.0

62.6

221

514

C08CA01

ATC

amlodipine; oral

2.9

62.3

543

2630

R60.0

ICD-10 Finland

Localized oedema

5.0

62.1

219

508

ZXA00

NOMESCO Finland

Right side

3.3

61.9

391

1519

WX213

NOMESCO Finland

Lower leg blockade

55.2

61.7

B03XA02

ATC

darbepoetin alfa; parenteral

18.0

61.4

TQW11

NOMESCO Finland

Vacuum treatment of wound

17.7

61.0

A12AA04

ATC

calcium carbonate; oral

19.6

60.7

Z94.0

ICD-10 Finland

Kidney transplant status

40.3

60.5

Z96.1

ICD-10 Finland

Presence of intraocular lens

4.4

60.0

242

643

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.7

59.9

606

3196

M14.2*E10.6

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic arthropathy

+∞

59.9

J01MA02

ATC

ciprofloxacin; systemic

2.8

59.7

585

3021

N18.8

ICD-10 Finland

Other chronic renal failure

13.5

59.6

106

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

4.9

59.5

214

506

H36.01

ICD-10 Finland

Diabetic maculopathy

20.1

59.3

L04AA06

ATC

mycophenolic acid; systemic

19.7

58.8

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.7

58.8

297

966

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

7.4

58.4

147

222

X59

ICD-10 Finland

Exposure to unspecified factor

3.6

58.4

310

1049

C07AB07

ATC

bisoprolol; oral

2.6

58.3

667

3761

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.5

57.8

230

602

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

52.0

57.7

M16.1

ICD-10 Finland

Other primary coxarthrosis

18.5

57.6

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

5.6

57.1

179

361

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

6.2

56.9

163

294

L28

ICPC

Limited function/disability (L)

4.0

56.2

256

758

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

6.7

56.2

152

254

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

30.6

56.0

H02AB06

ATC

prednisolone; systemic

2.6

55.7

627

3469

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

7.2

55.2

141

217

R4180

NOMESCO Finland

Podiatric therapy

34.1

54.5

I50.9

ICD-10 Finland

Heart failure, unspecified

4.2

54.4

233

651

SPAT1149

SPAT

Suture or treatment of traumatic wound

4.0

54.4

245

717

137

Kela drug reimbursment

Uraemia requiring dialysis

35.2

54.1

N03AX12

ATC

gabapentin; oral

4.0

54.1

242

704

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

39.8

54.0

N18.0

ICD-10 Finland

End-stage renal disease

28.0

54.0

M10.9

ICD-10 Finland

Gout, unspecified

10.4

53.9

109

114

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

3.5

53.7

288

975

Z3226

NOMESCO Finland

Physiotherapist

3.5

53.6

292

998

M14.2*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic arthropathy

+∞

53.5

M14.8

ICD-10 Finland

Arthropathies in other specified diseases classified elsewhere

+∞

53.5

RJ420

NOMESCO Finland

78.8

53.5

Z01.0

ICD-10 Finland

Examination of eyes and vision

3.5

53.3

291

997

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.8

53.3

438

1998

Z49.0

ICD-10 Finland

Preparatory care for dialysis

30.0

52.8

NF1AA

NOMESCO Finland

Hip X-ray examination

8.1

52.7

123

165

C10AA01

ATC

simvastatin; oral

2.5

52.6

623

3504

J01DA01

ATC

[U] cefalexin; systemic

2.6

52.6

854

5703

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

4.5

52.6

204

517

177

Kela drug reimbursment

Insulin glargine 300 U / ml

10.4

52.6

106

110

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

5.0

52.3

183

417

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

58.2

52.0

SPAT1229

SPAT

Assessment of need for aid

5.5

51.8

164

333

NH1AD

NOMESCO Finland

Ankle and foot CT

15.2

51.7

Z49.2

ICD-10 Finland

Other dialysis

36.6

51.5

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

140.9

51.2

C09AA02

ATC

enalapril; systemic

3.1

50.9

337

1327

N02BE01

ATC

paracetamol; systemic, rectal

3.1

50.8

1086

8429

S91.3

ICD-10 Finland

Open wound of other parts of foot

11.7

50.7

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

5.6

50.5

158

316

A52.1

ICD-10 Finland

Symptomatic neurosyphilis

+∞

50.3

127

Kela drug reimbursment

Transplant complication

18.4

50.0

B05DA

ATC

Isotonic solutions

38.9

49.9

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

40.7

49.5

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

9.9

49.3

102

111

ZXA05

NOMESCO Finland

Left side

3.0

49.2

354

1470

WX002

NOMESCO Finland

Sedation and analgesia

3.2

49.1

303

1130

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

7.1

48.7

125

193

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

7.8

48.6

117

164

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

5.7

48.3

147

284

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

14.5

47.9

104

Kela drug reimbursment

Thyroid insufficiency

4.9

47.8

167

378

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

7.2

47.8

121

183

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

12.4

47.8

V03AE02

ATC

sevelamer; oral

70.3

47.5

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

3.0

47.3

338

1392

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

21.1

47.1

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.5

47.1

530

2849

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

5.5

47.1

147

293

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.8

46.7

369

1615

L03.0

ICD-10 Finland

Cellulitis of finger and toe

5.4

46.5

150

310

TNG34

NOMESCO Finland

Major custom moulded orthopaedic cast, knee or lower leg

14.7

46.4

N02AA05

ATC

oxycodone; systemic

3.7

46.4

231

729

N02AJ06

ATC

codeine and paracetamol; systemic

2.6

46.3

466

2350

S20

ICPC

Corn/callosity

13.7

46.1

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

3.7

46.0

222

682

ZZA00

NOMESCO Finland

Split skin graft

8.6

45.6

102

127

P01BA02

ATC

hydroxychloroquine; oral

9.2

45.6

114

XF400

NOMESCO Finland

ECG with 12 standard connections

3.2

45.6

282

1049

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

10.9

45.5

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.7

45.5

222

688

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

47.8

45.4

Z01.8

ICD-10 Finland

Other specified special examinations

2.9

45.0

331

1381

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

8.9

44.7

118

D86.0

ICD-10 Finland

Sarcoidosis of lung

16.1

44.5

H3600, E113

ICD-10 Finland

15.7

44.2

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

121.9

44.0

Z3229

NOMESCO Finland

Other healthcare associate professional

4.1

43.8

186

509

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

5.8

43.8

131

247

C10AA05

ATC

atorvastatin; oral

2.4

43.6

533

2958

B05DB

ATC

Hypertonic solutions

38.3

43.5

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

3.4

43.3

234

782

Z3231

NOMESCO Finland

Registered nurse

2.6

43.3

408

1969

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.6

43.2

405

1946

A10BB12

ATC

glimepiride; oral

4.6

43.0

161

390

QDA10

NOMESCO Finland

Incision of skin of lower limb

28.9

42.9

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

8.8

42.7

114

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

8.1

42.6

131

A02BC02

ATC

pantoprazole; systemic

2.3

42.4

821

5660

J01CF05

ATC

flucloxacillin; systemic

7.1

42.0

107

163

RJ411

NOMESCO Finland

62.3

41.5

R4110

NOMESCO Finland

Physiotherapy

2.6

41.2

371

1736

NGQ20

NOMESCO Finland

Amputation of lower leg

38.7

41.2

TNH33

NOMESCO Finland

Custom moulded brace, ankle or foot

15.6

41.0

A07EC01

ATC

sulfasalazine; oral, rectal

8.2

41.0

122

L52

ICD-10 Finland

Erythema nodosum

25.9

40.9

TNX99

NOMESCO Finland

Other orthopaedic minor procedure

9.1

40.8

103

S91.1

ICD-10 Finland

Open wound of toe(s) without damage to nail

17.1

40.7

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

20.9

40.4

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

68.0

40.3

CKD40

NOMESCO Finland

Endophotocoagulation of retina

14.6

40.0

L16

ICPC

Ankle symptom/complaint

4.3

39.9

161

419

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

54.1

39.8

C02AC05

ATC

moxonidine; oral

6.1

39.4

112

198

E66.00

ICD-10 Finland

Metabolic syndrome

5.5

39.3

122

240

SPAT1263

SPAT

Sampling

2.2

39.0

575

3435

RJ414

NOMESCO Finland

89.0

39.0

NH3EA

NOMESCO Finland

Feet X-ray examination with load

52.9

38.8

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

9.4

38.7

N06AX21

ATC

duloxetine; oral

3.9

38.6

170

479

C08CA13

ATC

lercanidipine; oral

3.4

38.5

210

704

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

44.3

38.4

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

44.3

38.4

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

5.7

38.3

116

222

WX408

NOMESCO Finland

General anesthesy, balanced

2.5

38.2

393

1965

R06.0

ICD-10 Finland

Dyspnoea

2.6

37.9

328

1487

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.8

37.7

133

302

ZXE10

NOMESCO Finland

More than one and less than three hours

2.3

37.6

477

2644

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.5

37.3

355

1697

SPAT1211

SPAT

Application of soft bandage

4.1

37.3

157

424

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

21.2

37.3

NH1CM

NOMESCO Finland

Ankle and foot extensive MRI examination with 3 Tesla magnet

378.0

37.2

ZX120

NOMESCO Finland

Intravenous

3.7

37.0

177

534

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.2

36.9

666

4321

L89

ICD-10 Finland

Decubitus ulcer and pressure area

13.4

36.9

A10BH01

ATC

sitagliptin; oral

3.6

36.9

181

558

Z2446

NOMESCO Finland

Social worker

4.5

36.9

138

333

C09AA05

ATC

ramipril; oral

2.5

36.7

366

1790

H26.4

ICD-10 Finland

After-cataract

4.0

36.7

158

435

AA1AD

NOMESCO Finland

CT of head and brain

2.5

36.7

340

1600

XCW99

NOMESCO Finland

Other investigative procedure of eye

3.4

36.4

197

655

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

11.0

36.2

I79.2*E10.5

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

190.4

35.9

E66.01

ICD-10 Finland

Obesity due to excess calories

4.5

35.8

136

333

A10BJ02

ATC

liraglutide; parenteral

8.5

35.7

100

M14.8*L52

ICD-10 Finland

Arthropathy in erythema: nodosum

+∞

35.6

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

24.7

35.5

N17.9

ICD-10 Finland

Acute renal failure, unspecified

6.7

35.5

147

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

41.4

35.5

I50.0

ICD-10 Finland

Congestive heart failure

4.6

35.5

129

302

ZXE00

NOMESCO Finland

One hour or less

2.2

35.4

516

3028

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

16.5

35.4

S92.3

ICD-10 Finland

Fracture of metatarsal bone

6.9

35.3

141

D64.9

ICD-10 Finland

Anaemia, unspecified

3.6

35.1

174

540

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.8

35.0

269

1132

M86.1

ICD-10 Finland

Other acute osteomyelitis

80.5

35.0

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.6

34.9

298

1334

196

Kela drug reimbursment

Paricalcitol and cinacalcet

48.2

34.9

H28.0*E10.3

ICD-10 Finland

Other specified diabetes mellitus - Diabetic cataract

52.9

34.6

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

5.4

34.6

109

218

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

+∞

34.5

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

35.0

34.2

CJB10

NOMESCO Finland

Laser discission of secondary cataract

4.1

34.2

143

383

G47.3

ICD-10 Finland

Sleep apnoea

2.6

34.2

305

1397

G56.0

ICD-10 Finland

Carpal tunnel syndrome

3.4

34.2

178

574

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

21.6

34.1

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

13.3

34.1

SPAT1255

SPAT

Intravenous administration of medicine

4.2

33.7

137

357

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

4.2

33.5

134

344

ZXA10

NOMESCO Finland

Bilateral

2.7

33.5

269

1160

A10BB01

ATC

glibenclamide; oral

5.4

33.4

104

205

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.2

33.3

442

2466

E0000UV

ATC

2.1

33.2

521

3131

E66.8

ICD-10 Finland

Other obesity

5.5

33.2

102

198

SPAT1254

SPAT

Administration of medicine

3.0

33.2

213

797

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.6

33.1

161

491

RJ521

NOMESCO Finland

335.4

33.0

M86.8

ICD-10 Finland

Other osteomyelitis

76.3

33.0

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

12.8

33.0

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.3

33.0

399

2133

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

36.1

32.9

A41.9

ICD-10 Finland

Sepsis, unspecified

6.6

32.5

138

160

Kela drug reimbursment

exenatide

8.4

32.4

TPX10

NOMESCO Finland

Implantation of vascular injection port

6.9

32.1

125

R11

ICD-10 Finland

Nausea and vomiting

4.0

32.1

137

373

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

13.6

31.6

H25.8

ICD-10 Finland

Other senile cataract

3.4

31.6

165

532

H02AB04

ATC

methylprednisolone; systemic

3.0

31.4

207

786

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

3.5

31.4

159

500

M14.5*E83.1

ICD-10 Finland

Arthropathy in haemochromatosis

+∞

31.4

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

5.4

31.4

194

NHK99

NOMESCO Finland

Other operation on bone of ankle or foot

43.4

31.0

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

24.7

30.6

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

52.8

30.4

NH2AA

NOMESCO Finland

Heel X-ray examination

28.2

30.3

RJ410

NOMESCO Finland

59.9

30.2

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

19.0

30.2

A10AA03

ATC

13.9

30.2

M86.4

ICD-10 Finland

Chronic osteomyelitis with draining sinus

309.4

29.9

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

8.0

29.8

R5140

NOMESCO Finland

Monitoring the use of the aid

3.2

29.7

170

583

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

16.0

29.6

A28

ICPC

Limited function/disability NOS

2.9

29.4

204

799

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.6

29.4

242

1049

A06AD11

ATC

lactulose; oral

2.9

29.3

203

795

R50.9

ICD-10 Finland

Fever, unspecified

2.8

29.2

206

816

TNX39

NOMESCO Finland

Other orthopedic bandage, unspecified region

12.2

29.1

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

28.7

29.0

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.6

29.0

232

990

C03DA01

ATC

spironolactone; oral

3.2

29.0

168

583

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

6.1

29.0

140

J04AB02

ATC

rifampicin; systemic

21.7

28.8

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.4

28.8

297

1450

RJ126

NOMESCO Finland

153.5

28.8

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.4

28.7

280

1332

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

9.9

28.6

2504B

ICD-9 Finland

Diabetes mellitus, Diabetes with renal manifestations[DIABETES MELLITUS CUM COMPLICATIONE OCULI ,TYYPPI I]

37.0

28.5

A10BH05

ATC

linagliptin; oral

4.9

28.4

212

NH1FA

NOMESCO Finland

Weight-bearing X-ray of ankle

40.0

28.1

V03AE03

ATC

lanthanum carbonate; oral

65.5

28.0

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

65.5

28.0

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

4.2

28.0

113

292

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

33.6

27.9

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

79.5

27.9

M65.3

ICD-10 Finland

Trigger finger

5.4

27.8

168

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

27.8

431

2528

RJ120

NOMESCO Finland

102.4

27.8

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

3.7

27.7

129

378

N06AA09

ATC

amitriptyline; systemic

3.4

27.7

144

461

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

11.8

27.5

2501B

ICD-9 Finland

Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]

48.3

27.5

M20.1

ICD-10 Finland

Hallux valgus (acquired)

10.0

27.4

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

4.4

27.4

103

249

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

11.5

27.3

A10AB06

ATC

insulin glulisine; parenteral

11.5

27.3

NG4AA

NOMESCO Finland

Lower leg X-ray examination

7.1

27.2

101

212

Kela drug reimbursment

Gout

+∞

27.2

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

4.0

27.1

115

311

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

15.7

27.0

WX110

NOMESCO Finland

Local anesthesy

1.9

26.9

837

6362

B01AC04

ATC

clopidogrel; oral

2.6

26.8

224

973

C09BA02

ATC

enalapril and diuretics; systemic

3.3

26.8

144

472

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.9

26.8

183

708

G63.2

ICD-10 Finland

Diabetic polyneuropathy

28.4

26.8

E03.0

ICD-10 Finland

Congenital hypothyroidism with diffuse goitre

25.3

26.7

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

46.8

26.6

TK820

NOMESCO Finland

Peritoneal dialysis

29.9

26.4

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

26.4

26.3

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

11.0

26.2

JN3AD

NOMESCO Finland

Abdominal CT examination

3.7

26.1

122

358

J01DA09

ATC

[U] cefadroxil; inhalant, oral

2.1

26.0

359

1996

H3602, E103

ICD-10 Finland

31.7

26.0

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

9.1

25.9

J01CA04

ATC

amoxicillin; systemic

2.0

25.9

970

7846

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

265.7

25.8

132

Kela drug reimbursment

Sarcoidosis

19.1

25.8

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.7

25.5

195

807

XF600

NOMESCO Finland

Bloodpressure measurement

4.0

25.4

108

292

ZXD10

NOMESCO Finland

Scheduled procedure

2.0

25.4

472

2948

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

7.6

25.4

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

36.4

25.3

H26.2

ICD-10 Finland

Complicated cataract

11.3

25.0

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.9

25.0

488

3101

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

10.8

24.9

P01AB01

ATC

metronidazole; oral, rectal

1.9

24.9

496

3172

E10.01

ICD-10 Finland

Insulin-dependent diabetes diabetic coma with hyperglycemia

71.4

24.9

H25.1

ICD-10 Finland

Senile nuclear cataract

2.2

24.9

293

1514

J01MA14

ATC

moxifloxacin; systemic

3.2

24.8

140

475

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.0

24.7

150

535

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

5.1

24.7

165

XQ902

NOMESCO Finland

Other photography

32.8

24.7

A10BX07

ATC

[U] liraglutide; parenteral

10.6

24.7

UJF32

NOMESCO Finland

Coloscopy

2.1

24.7

323

1746

A10BJ06

ATC

semaglutide; parenteral

5.3

24.6

153

B01AA03

ATC

warfarin; systemic

2.4

24.5

242

1147

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

4.3

24.5

227

WZB00

NOMESCO Finland

Telephone receipt or other advice

2.1

24.5

355

2007

M48.0

ICD-10 Finland

Spinal stenosis

3.3

24.4

132

434

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.4

24.2

232

1083

E03.89

ICD-10 Finland

Other specified hypothyroidism

5.6

24.2

135

NE1AA

NOMESCO Finland

Pelvis X-ray examination

4.8

24.1

179

J01CE02

ATC

phenoxymethylpenicillin; oral

1.9

23.9

851

6633

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

9.6

23.9

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.4

23.9

229

1067

TNH31

NOMESCO Finland

Prefabricated orthosis, ankle or foot

15.4

23.9

XCD20

NOMESCO Finland

Photoangiography of eye

7.7

23.8

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.0

23.8

117

NH3DG

NOMESCO Finland

Very extensive MRI of foot

244.4

23.7

NH3CM

NOMESCO Finland

Extensive MRI of foot (more than 1.5 T)

244.4

23.7

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

5.7

23.7

126

C03AA03

ATC

hydrochlorothiazide; oral

3.0

23.6

148

539

162

Kela drug reimbursment

liraglutide

12.0

23.6

L03.9

ICD-10 Finland

Cellulitis, unspecified

8.4

23.5

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

2.0

23.5

420

2569

ZXE20

NOMESCO Finland

More than three and less than five hours

2.5

23.4

196

849

AN1

Coronary angiography

2.8

23.2

165

650

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

25.2

23.1

RJ210

NOMESCO Finland

55.1

23.1

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

5.5

23.1

134

ACC51

NOMESCO Finland

Release of median nerve

4.1

23.1

240

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

37.0

23.0

TNF34

NOMESCO Finland

Major custom moulded orthopaedic cast, hip or thigh

+∞

23.0

M14.2

ICD-10 Finland

Diabetic arthropathy

+∞

23.0

K02.1

ICD-10 Finland

Caries of dentine

1.8

22.9

680

4945

SPAT1325

SPAT

Vaccination

1.9

22.9

419

2578

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

3.0

22.9

140

501

J01CF02

ATC

cloxacillin; systemic

6.9

22.9

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

15.8

22.9

E66.9

ICD-10 Finland

Obesity, unspecified

5.9

22.9

115

WX892

NOMESCO Finland

Monitored bed care

3.2

22.8

127

424

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

4.5

22.8

194

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

16.8

22.8

H05BX01

ATC

cinacalcet; oral

26.4

22.7

NHK30

NOMESCO Finland

Osteotomy or rotation osteotomy of first metatarsal or tarsal bone

234.0

22.7

2505B

ICD-9 Finland

Diabetes mellitus, Diabetes with ophthalmic manifestations[NEUROPATHIA DIABETICA,TYYPPI I]

234.0

22.7

WX212

NOMESCO Finland

Femoral plexus blockade

10.6

22.7

WX140

NOMESCO Finland

Parabulbar anesthesy

4.2

22.7

229

A10BK03

ATC

empagliflozin; oral

3.3

22.7

122

400

NHS99

NOMESCO Finland

Other operation for infection of tendon, joint or bone of ankle or foot

122.2

22.6

TPH07

NOMESCO Finland

Cathetrisation of artery

2.8

22.6

159

624

M77.4

ICD-10 Finland

Metatarsalgia

4.9

22.6

164

M05BA04

ATC

alendronic acid; oral

3.3

22.5

119

385

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

6.1

22.4

106

171

Kela drug reimbursment

Degludekinsuliini

24.4

22.2

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

3.3

22.2

117

378

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.6

22.1

181

775

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.2

22.0

270

1409

H02AB07

ATC

prednisone; oral

2.5

22.0

186

810

WX100

NOMESCO Finland

Conjunctival surface anesthesia

2.8

22.0

155

607

S17

ICPC

Abrasion/scratch/blister

8.6

22.0

X58

ICD-10 Finland

Exposure to other specified factors

2.7

22.0

168

691

R53

ICD-10 Finland

Malaise and fatigue

2.2

22.0

256

1308

M14.5*E05.9

ICD-10 Finland

Arthropathy in thyrotoxicosis [hyperthyroidism]

+∞

21.9

RJ512

NOMESCO Finland

+∞

21.9

E87.5

ICD-10 Finland

Hyperkalaemia

10.3

21.9

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

63.7

21.9

TK810

NOMESCO Finland

Hemofiltration

18.8

21.8

L15

ICPC

Knee symptom/complaint

2.5

21.8

186

812

S76

ICPC

Skin infection other

4.1

21.8

228

H3603, E107

ICD-10 Finland

81.6

21.7

SPAT1249

SPAT

Treatment-related counselling outside office

1.8

21.7

481

3155

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

4.1

21.7

219

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

223.6

21.7

C10AX09

ATC

ezetimibe; oral

2.7

21.5

153

603

S09

ICPC

Infected finger/toe

6.3

21.5

B01AB04

ATC

dalteparin; parenteral

4.5

21.4

183

C01DA14

ATC

isosorbide mononitrate; oral

2.5

21.4

185

816

E83.1

ICD-10 Finland

Disorders of iron metabolism

23.6

21.3

6480A

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Diabetes mellitus

21.1

21.3

SPAT1216

SPAT

Assessment of functional ability

2.5

21.3

183

801

B01AB10

ATC

tinzaparin; parenteral

3.2

21.3

115

378

C09CA01

ATC

losartan; oral

2.0

21.3

305

1700

SPAT1153

SPAT

Removal of sutures

2.0

21.2

359

2132

R4120

NOMESCO Finland

Occupational therapy

3.6

21.0

288

K65.0

ICD-10 Finland

Acute peritonitis

9.4

20.9

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.8

20.9

510

3445

Z89.4

ICD-10 Finland

Acquired absence of foot and ankle

+∞

20.9

72410

ICD-8 Finland

Internal derangement of joint, Other shoulder derangement

+∞

20.9

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.7

20.9

273

Z2221

NOMESCO Finland

Medical doctor

1.9

20.7

361

2166

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

111.8

20.6

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

3.3

20.3

106

339

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

48.8

20.2

WX722

NOMESCO Finland

PEEP

3.9

20.1

234

3AC01

NOMESCO Finland

11.5

20.0

R05FB02

ATC

cough suppressants and expectorants

1.8

19.9

452

2965

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

12.8

19.9

JLE03

NOMESCO Finland

Allogenic total transplantation of pancreas with pancreaticoenterostomy

+∞

19.8

WX882

NOMESCO Finland

High dependency care

5.6

19.8

107

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

15.6

19.8

WX214

NOMESCO Finland

Plexus blockade at the ankle

74.7

19.7

E11.01

ICD-10 Finland

Non-insulin dependent diabetes diabetic coma with hyperglycaemia

74.7

19.7

L04AX01

ATC

azathioprine; systemic

4.4

19.7

174

A02BC01

ATC

omeprazole; systemic

2.0

19.7

314

1819

QDH05

NOMESCO Finland

Correction of deformity of toe nail

203.0

19.6

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.7

19.6

645

4749

QD6S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in foot

40.8

19.5

C07AB02

ATC

metoprolol; systemic

2.1

19.5

253

1347

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.6

19.5

262

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

10.9

19.5

J01EA01

ATC

trimethoprim; systemic

2.0

19.4

300

1712

J02AC01

ATC

fluconazole; systemic

1.8

19.4

469

3135

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

3.7

19.3

248

SPAT1301

SPAT

No procedures

1.9

19.3

375

2331

SPAT1151

SPAT

Treatment of major wounds

8.5

19.3

2507B

ICD-9 Finland

Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICAT ALIA ,TYYPPI I]

26.5

19.2

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

3.6

19.2

255

J01FA06

ATC

roxithromycin; oral

1.8

19.1

477

3217

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

3.2

19.0

102

334

B03XA01

ATC

erythropoietin; parenteral

12.0

18.8

L29

ICPC

Musculoskeletal sympt/complt other

3.4

18.8

297

NHS20

NOMESCO Finland

Incision and debridement of infection of bone of ankle or foot

+∞

18.8

RJ523

NOMESCO Finland

+∞

18.8

M10.0

ICD-10 Finland

Idiopathic gout

8.4

18.8

RD210

NOMESCO Finland

8.4

18.8

TKC20

NOMESCO Finland

Catheterisation of bladder

3.1

18.8

108

371

E16.0

ICD-10 Finland

Drug-induced hypoglycaemia without coma

28.3

18.8

RJ511

NOMESCO Finland

71.0

18.7

CKD70

NOMESCO Finland

Excision of preretinal or epiretinal membrane

7.8

18.7

A06AC01

ATC

ispaghula (psylla seeds); oral

2.0

18.7

279

1569

Z50.1

ICD-10 Finland

Other physical therapy

4.1

18.6

189

NHG20

NOMESCO Finland

Fusion of talocrural joint

192.7

18.6

E000001

ATC

2.0

18.5

264

1456

A02BC05

ATC

esomeprazole; systemic

1.8

18.5

455

3048

B03BA03

ATC

hydroxocobalamin; parenteral

3.5

18.5

268

TQW40

NOMESCO Finland

Remowal of suture of skin

3.3

18.5

301

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

5.6

18.4

100

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

5.7

18.4

N05CF01

ATC

zopiclone; oral

1.8

18.3

373

2345

C07AG02

ATC

carvedilol; oral

3.4

18.3

292

RJ421

NOMESCO Finland

44.7

18.3

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.7

18.2

484

3316

C08CA02

ATC

felodipine; oral

2.7

18.2

133

531

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

18.2

560

4012

WX204

NOMESCO Finland

Axillary plexus blockaced

6.0

18.1

NHK40

NOMESCO Finland

Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone

33.4

18.0

M20.2

ICD-10 Finland

Hallux rigidus

53.3

18.0

T82

ICPC

Obesity

4.7

17.9

134

SPAT1260

SPAT

Consultation of another employee

2.1

17.9

220

1141

M01AX17

ATC

nimesulide; oral

2.0

17.9

261

1453

H36.02

ICD-10 Finland

Preproliferative diabetic retinopathy

18.4

17.8

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.9

17.8

309

1836

L88

ICPC

Rheumatoid/seropositive arthritis

11.3

17.8

L04AA13

ATC

leflunomide; oral

67.6

17.8

L12

ICPC

Hand/finger symptom/complaint

2.4

17.6

154

680

H26.02

ICD-10 Finland

Presenil cataract

5.0

17.6

119

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

4.0

17.5

185

EBA15

NOMESCO Finland

Extraction of large number of teeth

3.9

17.4

191

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.9

17.4

191

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.5

17.4

140

590

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

3.4

17.4

276

B81

ICPC

Anaemia vit B12/folate deficiency

4.6

17.4

134

M54.5

ICD-10 Finland

Low back pain

1.8

17.4

352

2206

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.4

17.3

148

A10AD04

ATC

insulin lispro; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

21.2

17.3

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

21.2

17.3

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.3

17.3

288

M01AH01

ATC

celecoxib; oral (coxibs)

2.3

17.3

180

864

J01CE08

ATC

benzathine benzylpenicillin; parenteral

10.6

17.2

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.9

17.2

316

1913

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

5.9

17.2

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.2

17.1

186

912

WW200

NOMESCO Finland

Immunization

5.3

17.1

101

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

4.4

17.0

146

J01AA02

ATC

doxycycline; systemic

1.7

17.0

925

7737

B01AX06

ATC

[U] rivaroxaban; oral

50.7

17.0

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

9.7

16.9

UJF30

NOMESCO Finland

Ileoscopy through colon

2.6

16.9

132

547

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

16.9

309

1864

25002

ICD-8 Finland

Diabetes mellitus, Retinopathia diabetica

22.2

16.9

A10BK01

ATC

dapagliflozin; oral

3.5

16.9

249

M01AX05

ATC

glucosamine; oral

2.3

16.7

160

737

EBA10

NOMESCO Finland

Surgical removal of tooth

2.4

16.7

155

704

M146, E119

ICD-10 Finland

+∞

16.7

RJ412

NOMESCO Finland

+∞

16.7

M146, E114

ICD-10 Finland

+∞

16.7

WZC30

NOMESCO Finland

Teaching

2.3

16.7

172

823

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.7

16.7

116

448

NH1CF

NOMESCO Finland

Ankle and foot extensive MRI examination with median intensity magnet

91.3

16.6

M86.2

ICD-10 Finland

Subacute osteomyelitis

91.3

16.6

TNG10

NOMESCO Finland

Puncture of knee

172.1

16.5

E000006

ATC

2.9

16.5

101

362

E000003

ATC

3.5

16.5

232

D86.3

ICD-10 Finland

Sarcoidosis of skin

40.6

16.4

EBA00

NOMESCO Finland

Extraction of tooth

1.8

16.3

385

2522

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.4

16.3

245

M81.9

ICD-10 Finland

Osteoporosis, unspecified

4.4

16.3

143

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

10.6

16.2

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

4.1

16.2

163

L04AD01

ATC

ciclosporin; systemic

7.2

16.2

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.7

16.1

113

439

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.7

16.1

114

447

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.5

16.1

132

561

J45.9

ICD-10 Finland

Asthma, unspecified

2.1

16.1

202

1056

A12BA01

ATC

potassium chloride; oral

4.0

16.0

170

N19

ICD-10 Finland

Unspecified kidney failure

4.6

16.0

127

1220

FHL

Arthroscopy

7.0

16.0

SPAT1147

SPAT

Destruction of skin lesion with external methods

6.7

15.9

R5599

NOMESCO Finland

Other rehabilitation service

5.1

15.9

101

C10AA04

ATC

fluvastatin; oral

2.7

15.8

110

427

L60.0

ICD-10 Finland

Ingrowing nail

4.2

15.8

152

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

15.8

152

702

H16.0

ICD-10 Finland

Corneal ulcer

3.6

15.8

203

NF1DA

NOMESCO Finland

X-ray of hips

15.9

15.7

SPAT1210

SPAT

Application of cast or individual aid

3.9

15.7

178

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.9

15.7

100

368

A02BC03

ATC

lansoprazole; oral

1.8

15.7

320

1997

RJ513

NOMESCO Finland

+∞

15.7

7151F

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]

+∞

15.7

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

+∞

15.7

NHG70

NOMESCO Finland

Arthroplasty of first tarsometatarsal joint

+∞

15.7

M14.5

ICD-10 Finland

Arthropathies in other endocrine, nutritional and metabolic disorders

+∞

15.7

9271

FHL

Hallux surgery

+∞

15.7

RJ124

NOMESCO Finland

+∞

15.7

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

26.6

15.6

UKC02

NOMESCO Finland

Cystoscopy

2.1

15.6

188

963

RJ122

NOMESCO Finland

86.1

15.6

H28.0

ICD-10 Finland

Diabetic cataract

86.1

15.6

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

4.5

15.6

126

I25.2

ICD-10 Finland

Old myocardial infarction

2.9

15.6

346

RJ129

NOMESCO Finland

161.9

15.5

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

5.6

15.5

E03

ICD-10 Finland

Other hypothyroidism

3.1

15.5

283

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

9.1

15.5

A01

ICPC

Pain general/multiple sites

3.1

15.5

306

R60.9

ICD-10 Finland

Oedema, unspecified

3.7

15.5

196

R42

ICD-10 Finland

Dizziness and giddiness

1.9

15.4

238

1347

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

3.9

15.4

166

QDG00

NOMESCO Finland

Debridement of bedsore of lower limb

38.5

15.4

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.2

15.4

170

839

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.6

15.4

598

4499

SAA03

NOMESCO Finland

Extended examination of mouth

1.7

15.3

422

2883

S92.0

ICD-10 Finland

Fracture of calcaneus

10.6

15.2

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

6.1

15.2

M13.0

ICD-10 Finland

Polyarthritis, unspecified

29.0

15.2

J01XX08

ATC

linezolid; systemic

20.3

15.1

L03

ICPC

Low back symptom/complaint

1.9

15.1

244

1405

M01AE02

ATC

naproxen; oral, rectal

1.6

15.1

611

4634

Z96.4

ICD-10 Finland

Presence of endocrine implants

45.6

15.1

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.4

15.0

129

564

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.3

15.0

245

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

7.7

14.9

C09CA03

ATC

valsartan; oral

2.6

14.9

113

461

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

4.8

14.8

105

NH1DG

NOMESCO Finland

Ankle and foot very extensive MRI examination with high intensity magnet

32.1

14.8

A12AA12

ATC

[U] calcium acetate anhydrous; systemic

32.1

14.8

D86

ICD-10 Finland

Sarcoidosis

57.4

14.8

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.9

14.8

345

U14

ICPC

Kidney symptom/complaint

8.8

14.8

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

3.5

14.7

204

EB1WA

NOMESCO Finland

13.4

14.7

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

18.6

14.7

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

25.4

14.7

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

21.3

14.7

XG410

NOMESCO Finland

Flow-volume spirometry

3.7

14.7

184

L14

ICPC

Leg/thigh symptom/complaint

2.9

14.6

330

M146, E117

ICD-10 Finland

+∞

14.6

M146, E109

ICD-10 Finland

+∞

14.6

NHG82

NOMESCO Finland

Fusion of other tarsal joint

+∞

14.6

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

+∞

14.6

73799

ICD-8 Finland

Hallux valgus and varus

+∞

14.6

Z71.8

ICD-10 Finland

Other specified counselling

1.9

14.6

266

1592

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

12.0

14.6

M19.2

ICD-10 Finland

Other secondary arthrosis

81.0

14.6

WX111

NOMESCO Finland

Local infiltration anesthesia

81.0

14.6

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.6

14.6

112

461

KGH10

NOMESCO Finland

Operation for phimosis

5.0

14.5

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.7

14.5

105

417

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.9

14.5

227

1285

WX872

NOMESCO Finland

Intensive care

3.1

14.5

268

NK4AT

NOMESCO Finland

Puncture of joint with ultrasound guidance not elsewher classified

151.6

14.5

H3603, E109

ICD-10 Finland

151.6

14.5

25007

ICD-8 Finland

Diabetes mellitus, Coma diabeticum

151.6

14.5

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

10.2

14.5

ZX198

NOMESCO Finland

Other local administration

10.2

14.5

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.3

14.4

136

623

I50

ICD-10 Finland

Heart failure

5.0

14.4

H04.10

ICD-10 Finland

Dry eye syndrome

2.5

14.4

116

488

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

2.0

14.3

206

1134

25008

ICD-8 Finland

Diabetes mellitus, Complicatio alia definita

27.5

14.3

N04BC05

ATC

pramipexole; oral

2.9

14.2

324

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.9

14.2

240

1398

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

4.6

14.2

110

W00

ICD-10 Finland

Fall on same level involving ice and snow

2.4

14.2

131

591

M01AH05

ATC

etoricoxib; oral

1.6

14.2

590

4481

K59.1

ICD-10 Finland

Functional diarrhoea

3.3

14.1

233

NHL14

NOMESCO Finland

Shortening or lengthening of achilles tendon

43.0

14.1

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.0

14.1

291

L13

ICPC

Hip symptom/complaint

2.4

14.0

130

587

L04AA01

ATC

[U] ciclosporin; systemic

8.5

14.0

A10BX01

ATC

guar gum; systemic

3.9

14.0

155

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

9.0

14.0

W19

ICD-10 Finland

Unspecified fall

2.4

13.9

119

517

QDB99

NOMESCO Finland

Other procedure for wound of skin of lower limb

12.8

13.9

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

30.4

13.9

S01BC05

ATC

ketorolac; ophthalmic

3.6

13.9

177

D07AC01

ATC

betamethasone; topical

1.7

13.9

382

2598

XF402

NOMESCO Finland

ECG with work load test

2.3

13.8

137

643

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

11.6

13.8

I50.1

ICD-10 Finland

Left ventricular failure

3.6

13.8

183

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

24.1

13.8

A08

ICPC

Swelling

4.2

13.8

128

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.0

13.7

202

1120

S22

ICPC

Nail symptom/complaint

3.0

13.7

272

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

3.9

13.7

153

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

13.7

794

6525

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

3.1

13.7

259

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

3.0

13.6

268

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

+∞

13.6

RJ514

NOMESCO Finland

+∞

13.6

NH3BM

NOMESCO Finland

MRI of foot (more than 1.5 T)

+∞

13.6

NHL68

NOMESCO Finland

Tenodesis, shortening or lengthening of tendon of foot

34.4

13.5

WX290

NOMESCO Finland

Other blockade of nerve

1.6

13.5

484

3524

M01AB01

ATC

indometacin; systemic, rectal

2.9

13.5

305

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

8.9

13.5

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

6.9

13.5

J01MA01

ATC

ofloxacin; systemic

2.4

13.5

114

494

NH1EA

NOMESCO Finland

Ankle X-ray examination with load or wrench

141.4

13.5

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

141.4

13.5

SPAT1310

SPAT

Counselling related to known health issue

1.7

13.4

355

2381

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

4.8

13.4

-56

ICPC

Dressing/pressure/compress/tamponade

6.0

13.4

C02CA01

ATC

prazosin; oral

7.4

13.3

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.9

13.3

231

1359

321

Kela drug reimbursment

Paricalcitol and cinacalcet

14.0

13.3

NG2AA

NOMESCO Finland

Patella X-ray examination

14.0

13.3

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

2.3

13.2

123

559

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

3.3

13.2

212

XF404

NOMESCO Finland

Ambulatory ECG

2.4

13.2

117

519

M13.1

ICD-10 Finland

Monoarthritis, not elsewhere classified

40.5

13.2

NHK10

NOMESCO Finland

Incision or excision of metatarsal or tarsal bone

40.5

13.2

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.4

13.1

116

513

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

3.8

13.0

145

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

5.0

13.0

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

5.0

13.0

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

9.5

13.0

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.2

13.0

226

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

6.2

12.9

M02AA07

ATC

piroxicam; topical

1.6

12.9

381

2630

TNH32

NOMESCO Finland

Custom moulded split, ankle or foot

7.8

12.9

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.1

12.9

151

763

S92.4

ICD-10 Finland

Fracture of great toe

7.0

12.9

M09AX01

ATC

hyaluronic acid; parenteral

5.6

12.9

XCD10

NOMESCO Finland

Electrophysiological examination of eye

4.5

12.9

103

E14.4

ICD-10 Finland

Unspecified diabetes mellitus, with neurological complications

50.5

12.9

G59.0*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic mononeuropathy

50.5

12.9

S21

ICPC

Skin texture symptom/complaint

2.2

12.8

141

690

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

12.8

702

5645

M10

ICD-10 Finland

Gout

3.9

12.8

142

-50

ICPC

Medication/prescr/renewal

3.4

12.8

184

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

9.1

12.8

S01ED51

ATC

timolol, combinations; ophthalmic

2.5

12.8

404

M01AH02

ATC

rofecoxib; oral

2.3

12.6

124

578

Z5132

NOMESCO Finland

Nursing associate professional

15.6

12.6

H26.3

ICD-10 Finland

Drug-induced cataract

15.6

12.6

TPH00

NOMESCO Finland

Phlebotomy

15.6

12.6

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

12.6

395

2765

Z89.5

ICD-10 Finland

Acquired absence of leg at or below knee

70.6

12.6

3620B

ICD-9 Finland

Other retinal disorders, Diabetic retinopathy[RETINOPATHIA DIABETICA PROLIFERATIVA]

32.4

12.6

B01AF01

ATC

rivaroxaban; oral

2.6

12.6

366

KA1AE

NOMESCO Finland

Kidney ultrasound examination

4.9

12.6

N06AB04

ATC

citalopram; systemic

1.8

12.5

258

1599

QDH

NOMESCO Finland

Operations on toe nails

+∞

12.5

7350A

ICD-9 Finland

Acquired deformities of toe, Hallux valgus (acquired)

+∞

12.5

RJ211

NOMESCO Finland

+∞

12.5

M19.9

ICD-10 Finland

Arthrosis, unspecified

6.4

12.5

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

4.2

12.5

116

NHG26

NOMESCO Finland

Fusion between bones of ankle or ankle and foot

131.2

12.5

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

131.2

12.5

M86.0

ICD-10 Finland

Acute haematogenous osteomyelitis

131.2

12.5

RJ425

NOMESCO Finland

131.2

12.5

V03AE04

ATC

calcium acetate and magnesium carbonate; systemic

131.2

12.5

R04.0

ICD-10 Finland

Epistaxis

2.7

12.4

344

H3602, E113

ICD-10 Finland

13.3

12.4

R03AC02

ATC

salbutamol; inhalant

1.5

12.3

567

4360

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.8

12.3

242

1480

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.9

12.2

276

T79.3

ICD-10 Finland

Post-traumatic wound infection, not elsewhere classified

6.5

12.2

R06AE07

ATC

cetirizine; oral

1.6

12.2

473

3492

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

5.9

12.1

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

3.3

12.1

192

N05CD07

ATC

temazepam; oral

2.1

12.1

145

741

M22.4

ICD-10 Finland

Chondromalacia patellae

18.2

12.1

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

12.1

446

3248

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

4.1

12.1

115

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.8

12.0

214

1262

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.9

12.0

273

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

7.3

12.0

PG9AC

NOMESCO Finland

Arteriography with X-ray not elsewhere classified

21.5

12.0

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

21.5

12.0

XPX08

NOMESCO Finland

Intraoperative flow measurement

10.2

12.0

S01BC03

ATC

diclofenac; ophthalmic

4.6

12.0

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.6

12.0

377

S10

ICPC

Boil/carbuncle

3.1

12.0

222

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

3.3

12.0

194

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.8

12.0

228

1377

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

4.0

11.9

121

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.3

11.9

116

537

RJ630

NOMESCO Finland

47.1

11.9

N06AX11

ATC

mirtazapine; oral

1.6

11.9

343

2345

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.8

11.9

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

3.2

11.9

201

Z04.3

ICD-10 Finland

Examination and observation following other accident

5.3

11.8

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

7.1

11.8

XG466

NOMESCO Finland

Sleep oxymetry

3.8

11.8

132

CKD91

NOMESCO Finland

Extended vitrectomy through pars plana

5.9

11.8

H02AB09

ATC

hydrocortisone; systemic

4.6

11.8

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.5

11.8

414

TQW80

NOMESCO Finland

Local dermatologic skincare

4.1

11.7

113

R52.2

ICD-10 Finland

Other chronic pain

4.4

11.7

JN4BD

NOMESCO Finland

Extensive body CT

2.1

11.7

142

729

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

30.3

11.7

NG1DA

NOMESCO Finland

X-ray of knees

30.3

11.7

QXB10

NOMESCO Finland

Exchange of dressing for large skin wound, unspecified location

30.3

11.7

A10BX04

ATC

[U] exenatide; parenteral

7.0

11.6

A07AA02

ATC

nystatin; oral

2.7

11.6

298

I79.2

ICD-10 Finland

Peripheral angiopathy in diseases classified elsewhere

65.5

11.6

TBW99

NOMESCO Finland

Other minor procedure in endocrine surgery

65.5

11.6

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.7

11.6

300

1990

CKD93

NOMESCO Finland

Extended combined procedure on vitreous body and retina

11.2

11.6

WX202

NOMESCO Finland

Supraclavicular plexus blockade

7.2

11.5

SGA01

NOMESCO Finland

Tooth opening as first aid

1.9

11.5

179

1007

SAA04

NOMESCO Finland

Special inverstigation of mouth

2.9

11.5

256

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

3.3

11.5

183

M14.1*E21.5

ICD-10 Finland

Crystal arthropathy in hyperparathyroidism

+∞

11.5

7170A

ICD-9 Finland

Internal derangement of knee, Old bucket handle tear of medial meniscus

+∞

11.5

N083, E102

ICD-10 Finland

121.0

11.4

H3601, E117

ICD-10 Finland

121.0

11.4

E14.6

ICD-10 Finland

Unspecified diabetes mellitus, with other specified complications

121.0

11.4

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

5.4

11.4

S01ED01

ATC

timolol; ophthalmic

3.5

11.3

158

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

3.9

11.3

122

SPAT1215

SPAT

Assessment of need for medical rehabilitation

3.4

11.3

169

S11

ICPC

Skin infection post-traumatic

6.6

11.3

PB1AC

NOMESCO Finland

Angiography of upper extremity with X-ray

35.3

11.3

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

11.3

638

5102

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.8

11.2

128

D01AC02

ATC

miconazole; topical

2.3

11.2

102

459

1225

FHL

Arthroscopy and other therapeutic procedure

17.2

11.2

A41.8

ICD-10 Finland

Other specified sepsis

6.9

11.2

L29.9

ICD-10 Finland

Pruritus, unspecified

5.0

11.2

X57

ICD-10 Finland

Unspecified privation

4.4

11.1

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

12.8

11.1

M24.2

ICD-10 Finland

Disorder of ligament

25.3

11.1

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3042936) Bacteria identified in Isolate by Culture

489

1311

5.24

176.40

4.9

2.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

798

3282

4.41

161.97

7.6

3.9

mg/mmol

32.9

8.1

10.78

596

2088

(3012516) Albumin [Mass/volume] in Urine

771

3112

4.36

160.18

6.1

3.2

mg/l

375.6

382.0

0.02

587

1963

(3007853) Bacteria identified in Skin by Aerobe culture

425

1110

5.09

156.20

3.5

1.7

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

466

1314

4.85

155.80

6.7

2.5

22.2

23.5

0.84

417

1133

(3004789) Transferrin [Mass/volume] in Serum or Plasma

481

1393

4.77

155.44

6.4

2.4

g/l

2.1

2.3

8.72

446

1303

(3009508) Creatinine [Moles/volume] in Urine

777

3295

4.12

147.25

6.3

3.1

mmol/l

6.3

7.7

18.21

671

2781

(3022948) Iron [Moles/volume] in Serum or Plasma

491

1507

4.51

146.04

6.5

2.4

umol/l

11.8

13.6

3.46

462

1400

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

326

738

5.48

140.52

9.1

3.8

ng/l

153.7

89.2

9.79

297

648

(3003458) Phosphate [Moles/volume] in Serum or Plasma

455

1379

4.44

136.50

19.1

5.6

mmol/l

1.2

1.0

13.63

439

1291

(3020779) Urea [Moles/volume] in Serum or Plasma

354

943

4.71

124.45

22.2

7.8

mmol/l

13.7

9.6

17.95

341

901

(3026493) Urate [Moles/volume] in Serum or Plasma

605

2408

3.70

120.46

4.2

2.4

umol/l

3717.3

8023.3

1.64

531

2112

(42870588) Differential panel, method unspecified - Blood

724

3280

3.55

116.78

9.0

5.0

—

(3023368) Bacteria identified in Blood by Culture

640

2729

3.51

112.85

8.4

4.2

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

872

4574

3.47

108.22

15.6

6.3

mmol/l

1.2

0.42

819

4136

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

925

5062

3.52

106.41

19.7

7.0

mmol/l

1.2

0.18

786

4275

(3024561) Albumin [Mass/volume] in Serum or Plasma

836

4468

3.22

96.62

10.8

5.0

g/l

33.6

35.5

17.02

789

4170

(3006315) Basophils [#/volume] in Blood

895

5002

3.26

95.18

9.5

4.9

e9/l

0.0

2.62

793

4273

(3001604) Monocytes [#/volume] in Blood

892

4980

3.25

94.95

9.4

4.9

e9/l

0.6

4.74

790

4250

(3013115) Eosinophils [#/volume] in Blood

916

5198

3.28

94.69

9.6

5.3

e9/l

0.2

5.45

822

4496

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

245

611

4.66

91.80

6.9

3.5

kpa

5.2

0.14

238

568

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

782

4105

3.10

91.71

3.8

2.1

nmol/l

72.8

76.5

3.25

718

3687

(3022096) Basophils/100 leukocytes in Blood

835

4551

3.12

91.48

10.1

5.2

0.7

0.94

788

4250

(3019198) Lymphocytes [#/volume] in Blood

903

5149

3.19

91.20

9.5

5.0

e9/l

1.7

1.9

4.85

810

4480

(3009343) pH of Capillary blood

243

606

4.66

91.01

6.9

3.5

7.4

1.07

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

238

587

4.69

90.35

6.8

3.4

mmol/l

1.6

1.8

0.24

181

444

(3006504) Eosinophils/100 leukocytes in Blood

847

4693

3.09

89.34

10.2

5.1

3.1

2.8

2.56

797

4375

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

561

2471

3.14

89.34

3.3

2.0

mg/l

3.2

2.9

2.03

500

2085

(3019069) Monocytes/100 leukocytes in Blood

849

4723

3.08

88.67

10.5

5.4

8.7

8.6

0.12

801

4424

(3021788) Differential panel - Synovial fluid

20.34

85.56

1.5

1.2

—

(3002030) Lymphocytes/100 leukocytes in Blood

859

4874

3.03

85.34

10.2

5.2

24.7

27.9

15.47

802

4551

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

12.54

83.90

1.5

1.1

—

(3018010) Neutrophils/100 leukocytes in Blood

848

4806

2.99

83.90

9.7

5.0

59.8

57.3

8.45

795

4505

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

195

439

5.01

82.41

3.5

2.0

u/l

43.2

38.0

2.49

171

388

(3027945) Reticulocytes/100 erythrocytes in Blood

329

1097

3.63

81.83

3.8

2.6

1.9

1.8

1.11

298

973

(3018418) pH of Serum or Plasma

614

2964

2.93

81.27

12.0

4.0

7.4

0.15

141

571

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

152

278

6.02

80.85

4.8

2.9

mg/l

2.2

1.5

9.49

142

258

(3036481) Cortisol [Moles/volume] in Serum or Plasma

291

918

3.75

78.40

2.3

2.2

nmol/l

386.6

378.7

0.20

276

840

(3012095) Magnesium [Moles/volume] in Serum or Plasma

432

1746

3.15

78.20

4.6

3.5

mmol/l

0.8

1.79

403

1645

(3000475) Leukocytes [#/volume] in Synovial fluid

13.20

76.53

1.7

1.2

e6/l

9059.9

14131.5

0.39

(3023520) Reticulocytes [#/volume] in Blood

262

791

3.86

75.06

3.6

2.7

e9/l

72.9

70.6

0.41

198

600

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

143

265

5.91

74.90

3.1

2.1

mg/l

13.0

10.6

1.77

127

239

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

186

437

4.77

74.40

2.1

1.9

g/l

1.7

1.5

1.74

170

372

(3004588) Protein electrophoresis panel - Serum or Plasma

225

615

4.18

74.04

2.2

2.7

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

743

4142

2.73

72.08

2.5

1.9

pmol/l

98.2

93.6

1.30

408

2176

(3013650) Neutrophils [#/volume] in Blood by Automated count

948

5978

2.88

72.02

11.8

8.7

e9/l

4.5

4.1

4.77

838

5191

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

140

267

5.72

71.05

3.2

2.5

ug/min

219.3

137.8

0.64

170

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

318

1138

3.33

69.79

3.3

4.6

u/l

232.0

247.8

1.27

301

1081

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

564

2773

2.75

69.70

3.8

3.1

ng/l

3385.5

1333.6

7.94

474

2359

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

234

687

3.90

69.49

2.3

1.6

—

(3020630) Protein [Mass/volume] in Serum or Plasma

250

783

3.68

67.43

3.1

3.0

g/l

65.7

66.5

0.84

225

716

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

128

7.81

65.91

1.6

1.3

—

(3037522) Nuclear Ab [Titer] in Serum

297

1053

3.32

65.86

1.5

1.3

titre

552.8

481.7

0.29

190

(3001122) Ferritin [Mass/volume] in Serum or Plasma

763

4450

2.60

65.36

6.5

2.6

ug/l

148.9

138.0

0.65

712

4141

(3032080) INR in Blood by Coagulation assay

718

4081

2.59

64.74

13.1

8.8

inr

1.2

0.98

214

1170

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

186

486

4.27

64.66

9.8

3.7

mmol/l

23.6

24.0

0.66

169

445

(3019309) Folate [Moles/volume] in Red Blood Cells

422

1847

2.85

64.43

2.2

1.7

nmol/l

1162.1

1146.0

0.12

331

1414

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

388

1636

2.91

63.39

2.3

1.8

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

946

6172

2.70

63.38

10.8

5.0

mmol/l

8.6

6.7

49.26

896

5765

(3013707) Erythrocyte sedimentation rate by Westergren method

1072

7469

2.97

62.79

7.0

3.1

mm/h

20.0

11.5

31.39

1001

6844

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

876

5529

2.61

62.47

7.5

6.6

umol/l

9.7

11.8

9.33

835

5254

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1124

8107

3.11

60.29

14.0

7.2

u/l

88.8

78.2

10.31

1079

7623

(3022313) Gas panel - Capillary blood

171

444

4.26

59.79

7.5

3.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

125

251

5.38

59.77

3.1

1.6

—

(3002032) Base excess in Venous blood by calculation

273

981

3.22

58.70

10.3

3.5

mmol/l

1.2

1.8

1.45

236

784

(3021447) Carbon dioxide [Partial pressure] in Venous blood

273

989

3.20

57.85

10.2

3.5

kpa

5.9

0.41

261

962

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

114

7.68

57.68

8.4

7.4

mg/l

11.8

12.3

0.41

105

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

272

1010

3.11

55.06

6.0

3.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

105

203

5.52

52.25

10.5

5.5

iu/ml

865.4

1006.7

0.07

(3000991) Gas panel - Venous blood

242

876

3.14

50.92

14.8

9.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

441

2186

2.50

50.50

1.6

1.2

u/ml

1.6

1.9

0.18

123

562

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

630

3664

2.33

50.13

6.8

3.0

—

(3021960) Folate [Moles/volume] in Serum or Plasma

456

2315

2.45

49.38

1.9

1.5

nmol/l

20.0

20.5

0.26

401

1990

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

135

339

4.31

49.09

3.6

3.7

u/ml

0.3

1.60

186

(3017181) Myelocytes/100 leukocytes in Blood

220

770

3.21

48.89

5.2

4.1

0.9

1.0

0.04

226

(3021440) Promyelocytes/100 leukocytes in Blood

212

728

3.26

48.62

5.3

4.1

0.0

0.1

1.70

205

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

544

3004

2.34

48.49

2.6

2.1

u/l

166.8

238.8

1.51

513

2820

(3044640) Blood type and Crossmatch panel - Blood

568

3196

2.32

48.44

4.1

2.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

125

301

4.47

47.96

2.4

3.9

mg/l

121.4

43.8

0.88

100

252

(3015235) Bicarbonate [Moles/volume] in Capillary blood

112

247

4.85

47.89

4.3

3.3

mmol/l

24.2

25.2

1.19

105

224

(40768446) Kidney Pathology biopsy report

11.49

47.74

2.0

1.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

125

303

4.44

47.55

2.4

3.8

mg/l

48.2

63.8

0.36

101

255

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

22.42

47.37

7.2

5.6

—

(3042733) HLA Ab [Presence] in Serum

13.26

47.02

6.1

4.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

265

1055

2.87

46.79

2.9

1.6

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

15.82

46.13

1.5

1.1

54.1

67.1

0.60

(3026782) Osmolality of Urine

408

2027

2.44

45.81

4.9

2.6

mosm/kgh2o

483.6

548.7

8.54

369

1725

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

179

5.44

45.39

2.4

1.5

u/ml

101.0

108.0

0.33

(3002179) Metamyelocytes/100 leukocytes in Blood

202

702

3.20

45.26

4.5

4.0

0.6

0.05

156

(3000570) Elastase.pancreatic [Mass/mass] in Stool

114

267

4.57

45.25

1.7

1.4

ug/g

226.1

269.2

1.35

154

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

120

293

4.39

45.18

2.4

3.9

ratio

1.3

1.8

—

(3002582) Erythrocytes [#/volume] in Urine

543

3072

2.27

44.93

6.2

3.0

e6/l

90.5

63.3

0.42

447

2321

(3037467) Urinalysis macro (dipstick) panel - Urine

985

7100

2.36

44.68

7.8

3.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

201

5.12

44.58

2.5

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

26.41

44.58

10.3

7.8

mmol/l

6.8

5.3

0.51

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

248

981

2.86

44.14

2.5

2.3

g/l

0.2

0.84

225

927

(3024354) Oxygen [Partial pressure] in Venous blood

220

816

3.02

44.00

6.8

2.8

kpa

5.3

4.6

2.66

205

792

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

455

2410

2.33

43.84

4.0

2.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

282

1199

2.70

43.66

1.3

1.1

u/ml

13.1

1.8

1.51

494

(3000494) Fungus identified in Specimen by Culture

280

1189

2.70

43.44

1.9

1.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

175

5.37

43.38

1.6

1.2

u/ml

324.6

245.5

1.68

106

(3025159) Blasts/100 leukocytes in Blood

194

676

3.18

43.19

5.3

4.1

0.0

0.6

0.67

167

(3000850) Epithelial cells [#/volume] in Urine

409

2090

2.36

42.64

4.9

2.5

e6/l

6.5

6.0

0.16

375

1825

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

553

3208

2.21

42.47

6.5

2.6

u/l

52.0

58.2

2.60

510

2965

(1616796) Gas panel - Central venous blood

100

225

4.71

41.67

7.0

3.5

—

(36304419) Bacteria [Presence] in Urine

490

2726

2.24

41.55

5.8

2.9

—

(3026008) Bacteria identified in Urine by Culture

521

2974

2.21

41.43

4.2

2.9

—

(3030467) Casts [#/volume] in Urine by Automated count

498

2792

2.23

41.40

6.1

2.9

e6/l

0.4

0.5

0.22

405

2069

(3018095) Leukocytes [#/volume] in Urine

594

3582

2.16

40.97

7.1

3.4

e6/l

93.6

140.8

0.84

469

2491

(3018677) aPTT in Platelet poor plasma by Coagulation assay

338

1613

2.45

40.88

2.8

2.2

30.3

29.8

0.84

320

1568

(3007164) IgA [Mass/volume] in Serum or Plasma

378

1898

2.37

40.77

1.7

1.5

g/l

2.6

2.5

0.65

223

1185

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

190

5.00

40.45

1.6

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

136

395

3.71

40.25

2.3

2.1

ug/l

3.1

1.4

0.83

122

359

(40760888) Immunoglobulin light chains.free panel - Serum

219

4.69

40.23

2.1

4.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

630

3914

2.12

39.92

5.6

3.4

ng/l

71.8

63.1

0.15

489

2627

(40767503) Oxygen content in Capillary blood by calculation

201

4.83

39.70

4.2

2.6

15.3

16.5

1.64

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

126

355

3.81

38.95

2.5

2.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

126

355

3.81

38.95

2.5

2.4

g/l

7.7

7.1

2.35

260

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

126

355

3.81

38.95

2.5

2.4

g/l

4.1

3.8

0.89

251

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

121

332

3.90

38.84

2.3

2.5

g/l

3.1

3.0

0.29

255

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

263

1143

2.61

38.59

2.1

1.7

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

114

302

4.03

38.42

2.4

2.3

g/l

0.9

1.3

0.32

262

(3015377) Calcium [Moles/volume] in Serum or Plasma

581

3542

2.11

38.27

5.3

3.7

mmol/l

2.3

2.4

1.94

502

3142

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

149

5.41

38.17

1.4

1.2

—

(3044941) Cell count panel - Synovial fluid

9.66

38.15

1.6

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

285

1297

2.51

37.92

1.3

1.2

iu/ml

30.9

17.7

0.55

357

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

413

2211

2.24

37.87

1.8

mg/l

1.2

1.3

0.32

322

1662

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

706

4639

2.07

37.86

6.1

3.9

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

227

932

2.72

37.24

9.5

7.8

mmol/l

1.3

1.4

0.86

219

900

(3024471) HLA-A [Type]

11.44

37.23

1.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

103

259

4.22

37.22

11.3

2.1

nmol/l

1.1

0.8

1.67

215

(3031040) Bacteria [#/volume] in Urine by Automated count

923

6748

2.12

36.41

7.3

4.1

e6/l

833.8

2588.3

0.83

102

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

105

273

4.08

36.27

2.4

2.3

g/l

0.0

0.28

244

(3021901) Oxygen saturation in Capillary blood

185

4.71

34.93

4.1

3.0

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

256

1150

2.51

34.78

2.1

1.7

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

176

4.76

34.20

8.5

2.6

—

(3024932) HLA-DR beta [Type]

10.84

34.09

1.0

1.1

—

(40768797) Stomach Pathology biopsy report

282

1336

2.40

34.04

1.3

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

228

4.25

33.86

2.9

3.1

umol/l

31.5

35.4

0.71

190

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

114

330

3.68

33.80

2.6

2.4

g/l

10.3

10.6

0.19

275

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

6.37

33.23

1.4

1.1

u/l

46.6

58.3

1.14

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

119

359

3.53

33.15

2.2

2.4

ug/l

283.1

482.7

0.80

113

339

(3021589) Normoblasts [#/volume] in Blood

687

4614

1.98

33.11

19.7

8.4

e9/l

0.0

0.11

557

3706

(3033658) Prothrombin time (PT) actual/Normal

465

2723

2.07

33.04

7.1

3.8

90.7

90.0

0.26

455

2659

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

558

3497

2.00

32.75

3.8

3.1

u/l

30.6

35.1

0.98

525

3334

(3013512) EKG study

496

2982

2.04

32.72

5.9

3.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

102

280

3.85

32.64

2.5

2.2

g/l

36.1

37.8

1.74

240

(3020876) Protein [Mass/time] in 24 hour Urine

6.72

32.51

2.7

2.2

—

2.1

—

(3012501) Base excess in Blood by calculation

233

4.06

31.23

7.4

4.2

mmol/l

2.9

2.6

0.32

164

(3048929) Epstein Barr virus Ab [Presence] in Serum

102

289

3.73

31.18

1.6

1.2

—

(3037121) Protein [Mass/volume] in Urine

116

358

3.45

31.17

5.1

3.4

g/l

0.5

0.3

1.94

145

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

258

3.88

30.85

2.5

2.3

g/l

0.0

0.49

230

(3006184) Hemoglobin [Mass/volume] in Capillary blood

188

4.40

30.62

3.3

2.5

g/l

121.0

130.9

2.42

137

(3035350) Ketones [Presence] in Urine by Test strip

715

4952

1.92

30.61

5.5

3.2

estimate

0.0

0.00

161

870

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

255

3.88

30.57

2.6

2.3

g/l

0.0

0.00

230

(46235355) HIV 1 and 2 tests - Meaningful Use set

330

1746

2.17

30.23

2.8

1.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

280

1386

2.28

30.22

2.9

1.6

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

105

312

3.56

29.89

2.0

1.5

titre

430.0

124.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

150

554

2.92

29.78

1.8

1.9

g/l

1.4

1.5

0.16

133

511

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

309

1607

2.19

29.49

4.7

2.7

e6/l

4.3

2.4

1.79

181

847

(3037756) Immunofixation for Serum or Plasma

198

4.23

29.47

1.2

2.0

—

(3010421) pH of Blood

282

3.66

29.27

7.5

4.0

7.4

1.26

228

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

287

3.64

29.24

1.6

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

317

1675

2.16

29.01

4.6

2.6

e6/l

1.2

0.09

191

918

(3005719) IgG [Mass/volume] in Serum or Plasma

175

713

2.67

28.79

2.3

2.7

g/l

10.6

10.5

0.05

157

653

(3027801) Oxygen [Partial pressure] in Arterial blood

248

1190

2.32

28.68

10.4

9.1

kpa

11.8

12.4

0.91

237

1140

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

248

1190

2.32

28.68

10.4

9.1

kpa

5.2

5.1

0.81

237

1138

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

212

4.05

28.49

1.8

1.6

iu/ml

0.1

0.3

0.45

(40758558) Short blood count panel - Blood

434

2590

1.99

28.46

8.1

6.3

—

(3003396) Base excess in Arterial blood by calculation

248

1196

2.31

28.32

10.4

9.1

mmol/l

0.8

1.1

0.41

212

938

(3019225) pH of Specimen

217

987

2.42

28.32

12.1

4.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

8.11

28.22

27.7

27.0

ug/l

91.9

115.6

1.70

(3004775) Volume in Urine collected for unspecified duration

5.70

28.17

2.4

2.5

836.1

592.6

2.22

(3024928) Oxygen saturation in Venous blood

246

3.80

28.17

5.2

3.1

—

(3009261) Glucose [Presence] in Urine by Test strip

710

5005

1.86

27.80

5.6

3.3

estimate

0.0

1.08

143

845

(3021601) Nitrite [Presence] in Urine by Test strip

704

4952

1.86

27.73

7.5

4.5

estimate

0.0

0.50

166

886

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

221

3.88

26.90

1.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

458

2834

1.92

26.67

2.2

1.6

mmol/l

1.5

1.4

0.99

394

2365

(3016502) Oxygen saturation in Arterial blood

221

1049

2.32

26.05

11.2

9.7

95.3

95.6

0.33

213

1018

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

5.54

25.84

1.3

1.2

nmol/l

1.0

1.5

1.85

(3021879) Hepatitis B virus core Ab [Presence] in Serum

157

641

2.64

25.63

1.9

1.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

244

1216

2.22

25.57

2.9

2.8

umol/l

5.5

8.5

3.26

210

1068

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

139

535

2.78

25.46

10.8

11.5

mmol/l

24.0

24.4

0.44

123

504

(3008757) Leukocyte morphology finding [Identifier] in Blood

102

5.26

25.37

4.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

143

4.49

24.99

3.7

4.1

1.2

1.5

0.34

112

(3052851) Hemolysis interference index of Serum or Plasma

282

3.42

24.94

4.4

3.4

—

(3028271) Lactate [Moles/volume] in Capillary blood

156

4.32

24.92

2.9

1.8

mmol/l

1.5

1.7

0.75

148

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1025

8265

1.94

24.83

6.5

3.8

pmol/l

15.2

14.7

5.61

948

7506

(3014271) Vancomycin [Susceptibility]

8.55

24.07

3.3

2.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1246

10855

2.57

24.01

39.9

12.5

mg/l

23.5

25.8

1.99

1124

8238

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

375

2243

1.92

23.72

2.2

1.7

pmol/l

446.1

27472370.6

1.94

301

1871

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1186

10144

2.23

23.41

13.9

5.4

mmol/mol

51.4

39.8

95.02

1125

9344

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1173

9994

2.18

23.31

7.7

4.5

mu/l

2.2

0.04

1100

9119

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

5.73

23.13

1.6

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

147

611

2.57

23.07

1.6

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

10.17

22.98

1.5

1.0

e6/l

491310.4

32542.7

0.81

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

7.24

22.96

2.4

ug/min

423.2

158.8

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

104

4.95

22.83

1.7

—

(4146454)

105

4.90

22.57

4.2

2.7

—

(3022217) INR in Platelet poor plasma by Coagulation assay

241

1255

2.12

22.38

31.3

22.1

inr

1.4

1.3

0.16

158

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

110

401

2.89

22.25

2.3

1.9

—

(36660697) Celiac disease serology panel - Serum

170

774

2.37

21.88

1.3

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

108

4.77

21.84

1.2

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

8.39

21.43

3.1

3.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

5.98

21.42

1.3

1.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

200

984

2.21

21.40

11.9

10.3

g/l

113.2

123.0

8.51

193

953

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

136

4.25

21.15

1.4

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

240

3.39

21.01

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

173

3.83

20.91

1.6

1.7

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

5.13

20.53

2.9

4.3

63.2

58.6

0.57

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

176

836

2.27

20.48

11.6

3.5

mmol/l

1.2

1.89

162

718

(3016750) Collection duration of Urine

5.72

20.46

2.4

min

519.3

491.0

0.82

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

114

4.51

20.46

2.4

2.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

140

603

2.47

20.33

2.0

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

253

3.25

19.96

1.6

1.5

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

210

3.46

19.62

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

210

3.46

19.62

1.5

1.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

201

3.51

19.49

1.1

iu/ml

141.8

2692.1

0.48

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

912

7355

1.71

18.98

4.8

3.0

u/l

64.5

49.3

4.40

851

6883

(3014148) Varicella zoster virus Ab [Titer] in Serum

121

4.25

18.98

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

207

3.40

18.63

1.5

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

136

4.01

18.62

1.6

—

(3044927) Protein electrophoresis panel - Urine

4.61

18.54

1.3

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

155

3.79

18.48

1.4

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

137

3.98

18.43

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

179

3.58

18.42

1.4

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

8.41

18.42

1.1

1.0

—

(40761536) Microorganisms panel - Urine sediment

174

860

2.17

18.29

6.7

3.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

353

2225

1.79

18.20

7.1

4.1

—

(3004616) Nuclear Ab [Presence] in Serum

4.77

18.06

1.3

1.2

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

8.12

17.93

1.1

1.3

iu/ml

266.9

217.4

0.28

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

9.68

17.92

1.9

1.1

28.6

21.1

0.29

(3014576) Chloride [Moles/volume] in Serum or Plasma

241

1353

1.95

17.88

11.6

7.4

mmol/l

102.9

104.5

4.34

231

1327

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

5.42

17.84

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

7.62

17.00

1.1

1.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

258

3.02

16.82

2.1

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

155

757

2.18

16.75

3.8

2.5

ml/min/173m2

46.7

68.5

9.10

304

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

5.88

16.69

1.4

1.0

u/l

50.1

25.1

0.43

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

138

3.80

16.66

1.5

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

124

553

2.37

16.63

14.5

13.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

362

2.68

16.60

2.2

1.8

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

9.21

16.46

2.5

1.3

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

10.72

16.46

1.6

ug/l

0.4

0.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

133

617

2.28

16.28

3.3

3.5

pmol/l

4.2

4.5

4.01

119

548

(3025941) Bacteria identified in Stool by Culture

120

533

2.37

16.23

1.4

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

109

4.14

16.22

1.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

333

2.72

16.05

1.9

2.2

96.7

89.9

1.82

312

(3005988) Vibrio sp identified in Specimen by Organism specific culture

110

4.10

16.02

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

110

4.10

16.02

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

4.71

15.69

1.1

1.2

—

(3019060) Gas panel - Arterial blood

143

696

2.18

15.56

6.8

6.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

346

2256

1.71

15.49

4.5

3.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1255

11366

2.18

15.40

43.9

14.9

mmol/l

138.8

139.7

25.09

1233

11031

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

109

4.04

15.38

1.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

101

4.15

15.23

16.5

5.9

mmol/l

9.7

7.5

1.43

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

110

4.00

15.19

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

110

4.00

15.19

1.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1257

11409

2.18

15.04

44.9

15.0

mmol/l

4.1

4.0

25.54

1235

11050

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

232

2.98

14.87

1.9

1.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

225

1310

1.86

14.75

6.6

4.2

33.4

32.6

0.45

180

874

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

5.36

14.70

1.6

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

5.48

14.51

1.7

1.5

u/l

10.2

8.1

0.16

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

5.27

14.41

1.6

—

(3024263) Appearance of Synovial fluid

9.55

14.35

2.0

1.0

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

305

2.69

14.34

2.1

2.5

234.4

194.0

2.94

292

(3048689) Calprotectin [Mass/mass] in Stool

200

1134

1.89

14.22

2.3

ug/g

145.4

130.5

0.26

155

894

(21494890) Protein electrophoresis panel - 24 hour Urine

102

4.01

14.20

1.7

2.6

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

5.90

14.02

1.4

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

5.90

14.02

1.4

1.5

—

(3008898) HLA-B27 [Presence]

225

2.93

13.84

1.0

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

297

1914

1.70

13.68

3.3

3.1

mmol/l

2.5

1.05

242

1700

(3003181) Sodium [Moles/volume] in Urine

179

3.16

13.58

1.4

1.3

mmol/l

57.4

62.0

0.35

145

(3002619) Bacteria identified in Specimen by Culture

11.78

13.54

1.9

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

5.08

13.39

1.5

1.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

307

2008

1.68

13.34

4.9

3.5

ng/l

704.1

538.1

0.20

251

1529

(40768443) Skin Pathology biopsy report

407

2.38

13.01

1.3

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

4.17

12.80

1.0

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

4.99

12.66

1.5

1.4

—

(3017704) Immunofixation for Urine

4.99

12.66

1.1

2.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1168

10477

1.76

12.56

31.4

11.8

ml/min/173m2

72.2

81.6

23.46

1046

8528

(3029937) Albumin [Presence] in Urine by Test strip

378

2640

1.60

12.54

6.4

3.4

estimate

0.0

1.08

146

860

(3036489) Thrombin time

401

2.36

12.53

1.9

2.0

22.0

21.7

0.28

358

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

178

1012

1.87

12.48

6.8

2.4

u/l

33.2

87.4

0.61

142

868

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

173

3.08

12.39

1.4

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1119

0.31

12.21

1.5

1.7

—

(3017732) Neutrophils [#/volume] in Blood

126

641

2.06

12.19

4.1

3.2

e9/l

4.3

4.1

0.33

510

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

152

830

1.93

12.04

3.1

2.8

ng/l

290.6

199.7

1.52

134

759

(3036603) Volume of Urine

4.26

12.02

1.6

1.5

1965.5

1987.2

0.02

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

150

3.21

12.01

1.7

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

273

2.61

11.96

1.1

u/ml

12.3

3.6

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

193

2.93

11.96

1.4

1.2

u/ml

44.1

8.2

—

(3022145) Colonoscopy Study observation

194

1152

1.80

11.80

1.3

—

(3045414) Leukocytes [Presence] in Urine

394

2.32

11.70

2.3

1.7

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

157

876

1.89

11.65

2.4

2.5

ug/l

6.1

7.4

0.76

133

774

(3035637) Corticotropin [Mass/volume] in Plasma

128

3.35

11.55

1.7

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

192

2.89

11.48

1.4

1.2

u/ml

3.0

2.5

—

(3032057) Clostridioides difficile [Presence] in Stool

7.70

11.43

1.6

2.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

25.24

11.15

5.4

3.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

293

2.46

10.82

1.6

1.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

4.04

10.52

2.4

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

116

612

1.98

10.14

1.4

1.2

u/ml

285.5

243.1

0.12

105

553

(3045424) Erythrocytes [Presence] in Urine

155

2.97

10.14

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

5.06

10.06

2.3

2.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

4.19

9.92

1.8

1.2

nmol/l

0.9

1.2

0.83

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

105

3.39

9.90

2.0

2.2

mg/l

25.0

18.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

106

3.36

9.76

5.7

2.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

188

2.72

9.62

1.1

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

102

525

2.02

9.57

10.6

3.3

mmol/l

24.7

25.0

0.25

513

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

767

0.28

9.42

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

100

3.36

9.20

3.8

3.7

—

(3007566) Smooth muscle Ab [Titer] in Serum

266

2.39

9.12

1.3

1.2

titre

121.2

85.5

—

(21494755) Public health laboratory ask at order entry panel

1187

0.42

8.99

1.3

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

118

654

1.88

8.92

10.9

8.7

mmol/l

24.6

24.5

0.15

108

617

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

167

2.75

8.89

1.2

1.3

u/l

30.0

31.6

0.04

141

(3010838) Calcium [Moles/time] in 24 hour Urine

4.37

8.88

1.6

1.7

—

(3041096) Erythrocytes [Presence] in Urine by Automated

371

2752

1.48

8.84

6.0

3.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

135

2.94

8.75

1.6

1.4

g/l

29.1

33.1

1.05

121

(3023199) Leukocytes [#/volume] in Pleural fluid

125

3.01

8.66

1.6

1.3

e6/l

4150.3

1647.7

0.46

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

3.42

8.65

1.5

2.2

u/field

2.7

1.7

0.43

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

+∞

8.34

5.8

0.0

g/l

1.6

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

5.05

8.15

1.7

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

274

2.28

8.11

1.4

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

489

3872

1.41

8.04

6.2

3.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

7.91

7.99

1.1

—

(3044889) 12 lead EKG panel

874

7629

1.40

7.99

5.3

3.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

359

2.09

7.77

2.6

2.7

—

(3051651) Icteric interference index of Serum or Plasma

3.57

7.71

3.9

4.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

4.01

7.63

1.2

ratio

1.1

—

(40761511) CBC panel - Blood by Automated count

1237

11583

1.67

7.62

36.6

11.9

—

(3016018) Differential panel - Cerebral spinal fluid

108

3.01

7.53

1.6

1.7

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

115

2.92

7.35

1.5

1.3

e6/l

40668.0

107692.9

0.65

(3019977) pH of Arterial blood

3.86

7.27

3.2

4.1

7.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

230

2.31

7.20

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

151

2.63

7.15

1.4

1.8

g/l

0.6

1.0

0.79

119

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

157

2.59

7.14

1.4

1.2

u/ml

40.8

41.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

7.74

7.12

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

5.23

6.97

1.4

1.1

—

(40761535) Cells panel - Urine sediment

130

800

1.69

6.92

6.5

3.1

—

(3025315) Body weight

13.85

6.89

5.2

4.8

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

308

2.10

6.84

1.2

miu/ml

314.9

215.5

0.70

147

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

3.81

6.82

1.1

1.3

—

71.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

133

833

1.66

6.63

1.9

1.7

—

(3012441) Differential panel - Pleural fluid

100

2.94

6.60

1.7

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1206

11304

1.54

6.46

7.2

4.6

mmol/l

2.3

2.8

60.65

1134

10422

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

6.15

6.43

1.2

2.1

—

(4035726)

153

1000

1.60

6.43

1.6

1.4

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

14.38

6.40

2.0

1.3

ng/l

221.5

126.6

—

(40768804) Tissue Pathology biopsy report

533

4405

1.34

6.33

2.3

2.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

161

2.46

6.31

1.2

1.1

—

(3004451) EKG impression Narrative

3.87

6.27

1.6

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

3.09

6.21

1.3

1.5

mmol/l

11.6

12.4

0.23

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

3.42

6.15

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

3.42

6.15

1.3

—

(3049717) Cytology report of Urine Cyto stain

394

1.90

6.05

2.3

2.6

—

(3022689) Creatine [Moles/volume] in Urine

4.55

5.99

1.2

—

(40768806) Pleura Pathology biopsy report

106

2.77

5.97

1.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

191

2.29

5.94

3.7

3.3

nmol/l

0.7

0.8

1.39

146

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1254

11896

1.61

5.93

20.0

9.1

u/l

26.1

26.6

0.57

1226

11465

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

426

1.86

5.92

10.2

7.8

1.6

0.28

402

(3042631) Mycobacterium sp identified in Specimen

143

2.49

5.81

2.9

2.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

3.63

5.77

1.1

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

3.63

5.77

1.1

1.7

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

5.04

5.75

1.3

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

3.27

5.74

1.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1141

10641

1.42

5.64

6.0

3.7

mmol/l

1.5

1.3

9.31

1053

9744

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

781

6889

1.31

5.60

3.2

2.9

—

(3011648) Oxygen content in Venous blood

2.83

5.59

3.1

1.9

10.6

11.4

0.38

(4268621)

2.76

5.55

2.3

2.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

285

2.01

5.52

1.6

2.1

u/l

8585.8

4076.7

0.34

119

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

3.65

5.49

1.1

1.0

miu/ml

1390.9

1557.2

0.30

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

2.80

5.48

1.5

2.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1173

11011

1.44

5.43

6.7

4.1

mmol/l

1.4

1.5

10.68

1097

10141

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

16.09

5.41

6.0

2.8

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

16.09

5.41

1.8

5.6

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

142

2.43

5.41

1.2

1.3

nmol/l

30.0

0.6

0.49

135

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1180

11093

1.45

5.38

6.7

4.2

mmol/l

4.2

4.7

45.86

1106

10287

(3047181) Lactate [Moles/volume] in Blood

323

1.93

5.38

11.5

9.8

mmol/l

1.3

0.04

283

(3044290) Cell count panel - Cerebral spinal fluid

213

2.15

5.37

1.8

1.6

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

149

2.38

5.34

1.6

1.3

u/ml

3.8

4.4

0.16

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

3.21

5.33

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

3.21

5.33

1.1

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

5.59

5.32

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

4.03

5.17

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

115

2.55

5.14

1.2

1.6

—

(3009542) Hematocrit [Volume Fraction] of Blood

1103

10271

1.37

5.13

35.0

13.7

37.5

39.9

12.26

710

7532

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

112

718

1.61

5.12

1.3

1.2

iu/ml

137.2

163.2

0.36

270

(4062490)

2.75

5.12

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

3.11

5.07

1.1

nmol/l

0.3

0.6

—

(3023410) Appearance of Cerebral spinal fluid

111

2.55

4.98

2.4

1.8

—

(3000330) Specific gravity of Urine by Test strip

498

1.71

4.90

5.1

3.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

2.73

4.86

1.4

1.3

g/l

5.8

7.3

1.09

(3028192) IgG subclass 2 [Mass/volume] in Serum

2.73

4.86

1.4

1.3

g/l

2.7

3.0

0.31

(3024139) IgG subclass 3 [Mass/volume] in Serum

2.73

4.86

1.4

1.3

g/l

0.3

0.4

0.90

(3048879) Bone marrow aspiration report

4.61

4.78

1.4

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

170

2.21

4.78

1.3

1.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

132

2.38

4.76

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

153

2.25

4.62

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

245

1.95

4.39

2.0

1.7

e6/l

1045.2

774.6

0.14

204

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

245

1.95

4.39

1.9

1.6

e6/l

87.5

11.2

0.61

196

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

2.75

4.36

1.7

1.8

—

(40757373) Influenza virus identified in Isolate

4.57

4.30

1.5

1.9

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

223

1699

1.37

4.30

1.6

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

126

2.33

4.28

1.1

1.3

nmol/l

—

(3022621) pH of Urine by Test strip

609

1.58

4.15

4.1

2.8

—

(3000034) Microalbumin [Mass/volume] in Urine

103

2.45

4.15

5.9

2.7

mg/l

130.5

23.9

1.07

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

2.73

4.09

1.3

1.2

mg/l

42.5

40.3

0.09

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

142

2.21

4.07

1.1

1.0

u/ml

6.1

2.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

3.04

3.97

1.0

—

(3002385) Erythrocyte distribution width [Ratio]

990

9196

1.27

3.89

43.4

15.5

14.0

13.7

11.06

974

8966

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

132

2.22

3.88

1.4

1.3

pmol/l

241.7

302.3

0.50

106

(3032773) Endomysium IgG Ab [Titer] in Serum

2.50

3.81

1.0

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

3.82

3.80

1.1

1.2

—

(4027681)

2.86

3.80

1.4

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

497

1.60

3.72

2.3

—

(44806071)

6.70

3.67

1.3

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

116

2.27

3.65

1.5

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

116

2.27

3.65

3.3

4.5

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.69

3.64

1.0

1.5

86.4

83.9

—

(3028433) Virus identified in Specimen by Culture

3.45

3.62

1.2

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

151

2.08

3.53

1.5

1.2

u/ml

1.8

5.4

0.91

(3023419) Bacteria identified in Sputum by Culture

131

2.16

3.53

5.0

2.7

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

10.04

3.50

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

3.35

3.48

1.1

1.0

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

2.63

3.48

1.6

1.1

u/l

1.4

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.91

3.47

1.9

2.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

2.59

3.39

1.2

1.1

—

(40768441) Liver Pathology biopsy report

2.52

3.38

1.3

1.4

—

(3020891) Body temperature

424

1.61

3.31

7.8

4.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

3.04

3.25

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

165

1.96

3.16

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

151

1139

1.37

3.12

3.5

4.5

ug/l

64.0

27.8

0.29

118

948

(3014051) Protein [Presence] in Urine by Test strip

188

1.88

3.07

3.2

2.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

153

1.98

3.06

1.2

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

231

0.34

3.05

1.4

1.6

—

(3014891) Appearance of Pleural fluid

5.02

3.05

2.0

1.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

175

1355

1.33

3.05

1.8

1.6

1.4

1.85

138

1209

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.47

3.05

5.4

3.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.47

3.05

5.4

3.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

271

1.72

3.01

1.4

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

4.31

2.99

1.0

1.2

—

(3017569) Oxygen content in Arterial blood

2.76

2.99

3.3

3.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

287

1.70

2.98

1.5

1.3

u/l

12.0

9.8

0.41

225

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

3.02

2.97

2.8

2.4

e6/l

2500.3

1413.5

—

(4306422)

148

1.98

2.96

1.3

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

142

1.99

2.91

3.5

2.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

149

1.97

2.91

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

247

2987

0.79

2.87

3.4

4.1

26.8

22.1

1.94

1449

(3019174) dRVVT (LA screen)

5.41

2.87

1.7

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

5.41

2.87

1.9

1.7

—

(42529406) Shigella sp [Presence] in Stool by Culture

275

1.70

2.87

1.4

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

2.31

2.85

1.4

1.1

titre

85.0

176.4

—

(4010399)

100

716

1.43

2.82

1.5

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

2.28

2.78

1.1

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

270

1.69

2.78

1.4

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

104

2.13

2.75

1.3

1.6

—

(4024509)

2.38

2.73

1.6

—

(3001019) Free T4 and TSH panel - Serum or Plasma

610

0.58

2.73

2.1

1.7

—

(3002256) Pathology report gross observation

180

1424

1.30

2.70

1.4

1.3

—

(3035880) pH of Pleural fluid

2.52

2.70

1.1

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

112

2.07

2.68

1.2

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

2.35

2.65

4.1

2.3

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

2.81

2.65

1.1

1.0

89.5

89.7

0.01

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

4.68

2.60

2.4

3.4

u/field

0.9

0.3

—

(3003338) MCHC [Mass/volume]

903

9576

0.83

2.58

44.0

16.3

g/l

329.7

332.9

19.66

894

9505

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

269

1.66

2.55

1.7

1.9

iu/l

3.5

4.5

0.65

101

(3044242) Glucose [Moles/volume] in Arterial blood

2.62

2.53

4.8

3.0

—

(3019150) Specific gravity of Urine by Refractometry

260

2170

1.24

2.53

5.6

3.5

kg/l

1.0

0.08

305

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

143

1.91

2.52

1.3

1.4

u/l

21.1

26.4

0.46

122

(44790047)

115

2.02

2.51

1.6

1.4

—

(44790048)

115

2.02

2.51

1.6

1.4

—

(44790049)

115

2.02

2.51

1.6

1.4

—

(44806118)

115

2.02

2.51

1.6

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.84

2.48

1.5

2.4

—

(4015189)

2.96

2.41

1.4

2.3

—

(3044009) aPTT.lupus sensitive (LA screen)

5.02

2.40

1.7

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.65

2.36

1.5

1.4

—

(3045142) Bone marrow Pathology biopsy report

125

1.94

2.36

1.3

—

(3047189) Immunofixation for 24 hour Urine

2.51

2.36

1.8

2.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

2.51

2.36

1.2

1.3

—

(3006270) Folate [Moles/volume] in Blood

2.16

2.35

1.3

1.2

nmol/l

345.4

389.2

—

(3008037) Lactate [Moles/volume] in Venous blood

237

1.66

2.34

5.9

2.9

mmol/l

1.5

0.13

230

(3045716) Anion gap in Serum or Plasma

2.57

2.27

5.7

3.0

mmol/l

8.4

10.5

—

(3045788) Cell count panel - Pleural fluid

106

2.00

2.26

2.0

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

172

1.76

2.22

1.5

1.6

—

(3005570) Glucose [Moles/volume] in Urine

114

1.94

2.21

2.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

3.35

2.18

4.0

1.9

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

150

0.33

2.15

1.2

1.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

3.51

2.05

1.3

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

3.51

2.05

1.7

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

279

1.56

2.02

1.1

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

104

1.94

2.01

1.1

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

2.01

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.82

2.00

1.7

1.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

3.34

1.96

1.1

1.3

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

4.56

1.94

1.0

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

4.56

1.94

1.2

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

1.89

0.0

1.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.19

1.88

5.3

2.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.19

1.88

1.1

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

245

1.57

1.85

7.2

3.4

mg/l

23.5

26.3

0.22

150

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

3.54

1.84

1.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

114

898

1.29

1.83

1.6

1.8

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

4.18

1.82

1.2

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

127

1018

1.27

1.78

1.7

1.9

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

2.04

1.75

1.2

1.3

—

(3010813) Leukocytes [#/volume] in Blood

1277

12501

1.30

1.75

53.2

18.4

e9/l

7.2

6.7

8.37

1251

12073

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

257

1.53

1.75

1.5

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

244

0.49

1.74

1.7

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.86

1.71

1.2

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

324

1.47

1.71

6.1

4.0

mmol/l

4.2

3.9

1.59

305

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.30

1.70

1.4

1.7

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.30

1.70

1.4

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.30

1.70

1.4

1.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

284

1.49

1.68

4.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

2.39

1.68

1.0

1.2

—

538.7

—

(3007461) Platelets [#/volume] in Blood

1275

12489

1.28

1.65

53.1

18.3

e9/l

262.0

249.8

7.85

1252

12095

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.81

1.65

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.81

1.65

1.1

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

2.81

1.65

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.81

1.65

1.1

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.81

1.65

1.1

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.58

1.61

2.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.15

1.61

1.3

1.1

—

(3006462) Nitrate [Presence] in Urine

2.51

1.60

6.8

3.5

—

(3024731) MCV [Entitic volume]

1275

12497

1.28

1.58

52.9

18.3

90.8

90.9

0.26

1259

12279

(3035941) MCH [Entitic mass]

1275

12498

1.27

1.57

52.9

18.3

30.0

30.3

9.55

1259

12279

(3026361) Erythrocytes [#/volume] in Blood

1275

12499

1.27

1.56

53.1

18.3

e12/l

4.3

4.5

33.29

1250

12072

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

1.93

1.54

1.3

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.98

1.54

1.4

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

1.98

1.54

2.9

1.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

400

1.39

1.53

1.5

1.7

—

(3000963) Hemoglobin [Mass/volume] in Blood

1275

12503

1.27

1.53

53.6

18.4

g/l

127.6

136.3

59.16

1260

12285

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.34

1.52

1.2

1.3

—

(3037556) Urate [Mass/volume] in Serum or Plasma

2.60

1.51

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

184

2149

0.83

1.51

2.7

2.8

ug/l

0.6

0.8

2.19

120

1369

(3000012) Reticulocyte production index

2.17

1.50

1.2

1.5

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.86

1.50

2.0

1.8

umol/l

13.4

19.0

—

(40768800) Prostate Pathology biopsy report

230

0.52

1.49

1.5

1.2

—

(1761868) Lipid panel - Serum or Plasma

381

4198

0.87

1.49

4.4

2.8

—

(3044007) Cell count panel - Peritoneal fluid

2.44

1.48

2.9

2.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

152

1274

1.22

1.46

13.6

6.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.38

1.45

1.0

1.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

2.38

1.45

4.0

2.2

ug/l

23.8

17.6

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

140

1.65

1.45

1.3

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

102

1.77

1.45

1.3

1.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.98

1.43

1.3

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.98

1.43

1.3

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.98

1.43

1.3

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.98

1.43

1.3

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

225

0.53

1.40

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

225

0.53

1.40

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.18

1.40

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

385

0.64

1.39

1.4

1.6

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

224

0.53

1.39

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

224

0.53

1.39

1.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

142

1.63

1.39

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

248

0.56

1.36

1.4

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

2.95

1.36

1.2

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.36

1.29

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.36

1.29

15.5

8.4

—

(4211845)

2.36

1.29

6.8

3.5

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

192

0.52

1.28

1.6

1.5

—

(3033799) Differential panel - Peritoneal fluid

2.29

1.27

2.5

2.1

—

(3051593) INR in Capillary blood by Coagulation assay

2.05

1.27

35.8

15.7

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1156

0.81

1.21

1.6

1.7

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

187

0.53

1.19

1.4

—

(3005033) Fetal Nuchal fold Thickness US

186

0.53

1.17

1.4

—

(3011412) CD3 cells [#/volume] in Blood

1.69

1.14

1.3

2.1

e9/l

0.7

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

267

1.40

1.13

1.2

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.01

1.12

6.5

3.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.39

1.09

1.4

1.1

91.2

95.3

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.39

1.09

1.4

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

795

1.22

1.09

2.7

2.2

nmol/l

11.7

13.0

0.87

706

(3010503) CD19 cells [#/volume] in Blood

1.83

1.09

1.3

2.1

e9/l

0.1

0.11

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.83

1.09

1.3

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

419

1.30

1.06

1.4

1.8

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.13

1.05

17.1

8.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

1.71

1.05

1.0

1.1

—

(4198724)

2.06

1.03

1.4

1.8

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.01

1.00

1.1

2.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

100

1.61

0.97

1.8

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.90

0.94

1.9

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

260

1.36

0.93

2.7

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

109

1.57

0.93

1.2

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

109

1.57

0.93

1.2

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

109

1.57

0.93

1.2

1.5

—

(40768795) Lymph node Pathology biopsy report

102

1.58

0.90

1.1

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

152

1.45

0.88

3.7

2.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.00

0.87

1.5

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.00

0.87

1.5

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

362

1.28

0.85

3.2

1.5

mu/l

301.3

317.8

0.07

330

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

165

0.60

0.82

1.0

1.5

—

(3000492) Spirometry study

117

1018

1.16

0.82

1.7

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.61

0.81

1.9

2.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

122

0.57

0.78

1.1

1.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

422

1.24

0.76

2.8

3.7

u/ml

1369.1

3272.4

0.34

367

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.77

0.76

1.0

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1102

10799

1.10

0.75

6.6

4.2

mmol/l

7.5

5.9

44.83

1000

9850

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.75

0.71

1.4

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

546

1.20

0.70

1.6

1.9

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

128

1.41

0.65

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

178

0.67

0.65

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

178

0.67

0.65

1.2

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

1.48

0.64

3.1

5.4

u/ml

531.7

46.1

—

(3016879) Cocaine [Presence] in Urine

315

1.25

0.62

2.8

1.9

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

192

1.31

0.59

1.4

1.3

—

(3006653) Thiamine [Moles/volume] in Blood

1.51

0.58

1.0

1.2

nmol/l

147.3

134.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.58

0.0

3.6

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.58

0.0

7.1

—

(3003694) ABO and Rh group [Type] in Blood

322

3044

1.08

0.53

1.5

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.43

0.52

1.2

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.62

0.52

1.0

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.41

0.51

5.2

6.6

—

(4094501)

292

0.78

0.51

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

1.39

0.50

1.4

1.9

—

(21494434) Karyotype in Bone marrow

1.42

0.50

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

163

1.29

0.48

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

684

1.13

0.46

1.3

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.43

0.46

1.1

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.43

0.42

1.4

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.43

0.42

1.4

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.43

0.42

1.4

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.43

0.42

1.4

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.43

0.42

1.4

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.43

0.42

1.4

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.56

0.42

1.2

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

482

1.15

0.41

1.5

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.52

0.41

1.2

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.52

0.41

1.4

1.8

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

385

3696

1.06

0.41

3.9

4.7

ug/l

1.8

2.9

3.02

338

3302

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.36

0.41

1.5

—

(44806420)

1.47

0.40

2.4

2.5

—

(3034426) Prothrombin time (PT)

1.43

0.39

1.8

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

986

0.91

0.38

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

154

1644

0.93

0.36

1.5

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

545

1.12

0.36

1.0

—

(3025130) Human papilloma virus identified in Specimen

153

1.25

0.35

1.8

1.9

—

(4034850)

383

0.86

0.34

13.2

8.9

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

303

1.16

0.33

1.5

—

(3027008) Opiates [Presence] in Urine

341

1.15

0.32

2.8

1.8

—

(3028300) Cannabinoids [Presence] in Urine

342

1.14

0.31

2.8

1.8

—

(3000764) Benzodiazepines [Presence] in Urine

342

1.14

0.31

2.8

1.8

—

(40768793) Breast Pathology biopsy report

272

0.84

0.30

1.6

1.3

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

1.30

0.30

1.0

1.3

mmol/l

6.0

5.9

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

1.29

0.30

4.3

3.6

u/ml

32.9

57.6

0.63

(3027944) Amphetamines [Presence] in Urine

336

1.13

0.28

1.8

1.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

375

0.88

0.28

1.3

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

183

0.82

0.27

1.0

1.1

u/ml

2.0

3.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.67

0.26

1.2

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.19

0.21

1.0

1.8

—

(3016228) CD19 cells/100 cells in Blood

1.19

0.21

1.4

1.8

8.4

6.6

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

8.9

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.21

0.0

2.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.8

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.16

0.21

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

507

0.92

0.18

1.2

1.3

iu/l

33.9

29.9

0.22

423

(3006442) Creatine [Moles/volume] in Serum or Plasma

1.15

0.15

2.0

1.5

—

68.8

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.78

0.14

13.4

14.6

nmol/l

620.9

823.6

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

221

0.90

0.12

1.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.14

0.10

1.2

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

381

0.94

0.09

1.8

1.6

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.06

0.09

1.2

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

116

1.12

0.09

1.1

u/ml

1.6

6.1

—

(44813793)

1.08

0.08

1.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

133

0.90

0.07

1.2

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.86

0.07

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

151

0.93

0.05

1.4

nmol/l

0.4

0.3

—

120

(1002224) Polysomnography panel

464

0.99

0.00

1.0

1.1

—

(4281824)

118

1.02

0.00

1.2

1.1

—

(3011288) Drugs identified in Urine by Screen method

237

1.01

0.00

3.9

2.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.00

0.00

13.6

3.0

—

(3020393) Adenovirus Ag [Presence] in Stool

0.00

0.0

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

312.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

0.0

1.5

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.0

2.2

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

2.0

—

1.5

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.0

1.0

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.99

0.00

1.8

1.4

g/l

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.0

1.1

—

(3015183) Erythrocyte sedimentation rate

0.98

0.00

1.0

1.3

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.0

1.9

—

15.4

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.00

0.0

5.7

—

9.7

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_ARTHINOTH and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_ARTHINOTH	2.188 [1.92, 2.49]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.057

During the follow-up period (1.1.1998 — 31.12.2019), 1169 out of 4053 females with M13_ARTHINOTH died.

Males

Parameter	HR [95% CI]	p-value
M13_ARTHINOTH	2.67 [2.33, 3.06]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.025

During the follow-up period (1.1.1998 — 31.12.2019), 1086 out of 3233 males with M13_ARTHINOTH died.

Mortality risk

Mortality risk for people of age

years, who have M13_ARTHINOTH.

N-year risk	Females	Males
1	0.189%	0.58%
5	1.151%	3.633%
10	2.664%	8.154%
15	5.292%	14.826%
20	9.235%	24.39%

Relationships between endpoints

↥

Index endpoint: M13_ARTHINOTH – Arthropathies in other diseases classified elsewhere

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Arthropathies in other diseases classified elsewhere

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints